data_10022 ####################### # Entry information # ####################### save_entry_information _Entry.Sf_category entry_information _Entry.Sf_framecode entry_information _Entry.ID 10022 _Entry.Title ; 3D Structure of amyloid protofibrils of beta2-microglobulin fragment probed by solid-state NMR ; _Entry.Type macromolecule _Entry.Version_type original _Entry.Submission_date 2006-06-27 _Entry.Accession_date 2006-06-28 _Entry.Last_release_date . _Entry.Original_release_date . _Entry.Origination author _Entry.NMR_STAR_version 3.1.1.61 _Entry.Original_NMR_STAR_version . _Entry.Experimental_method NMR _Entry.Experimental_method_subtype SOLID-STATE _Entry.Details . _Entry.BMRB_internal_directory_name . loop_ _Entry_author.Ordinal _Entry_author.Given_name _Entry_author.Family_name _Entry_author.First_initial _Entry_author.Middle_initials _Entry_author.Family_title _Entry_author.Entry_ID 1 Kentaro Iwata . . . 10022 2 Toshimichi Fujiwara . . . 10022 3 Yoh Matsuki . . . 10022 4 Hideo Akutsu . . . 10022 5 Satoshi Takahashi . . . 10022 6 Hironobu Naiki . . . 10022 7 Yuji Goto . . . 10022 stop_ loop_ _Entry_src.ID _Entry_src.Project_name _Entry_src.Organization_full_name _Entry_src.Organization_initials _Entry_src.Entry_ID 1 . ; Institute for Protein Research, Osaka Unibersity and CREST, Japan Science and Technology Agency ; . 10022 2 . ; Faculty of Medical Sciences, University of Fukui and CREST, Japan Science and Technology Agency ; . 10022 stop_ loop_ _Data_set.Type _Data_set.Count _Data_set.Entry_ID assigned_chemical_shifts 1 10022 stop_ loop_ _Datum.Type _Datum.Count _Datum.Entry_ID '13C chemical shifts' 113 10022 '15N chemical shifts' 26 10022 stop_ loop_ _Release.Release_number _Release.Format_type _Release.Format_version _Release.Date _Release.Submission_date _Release.Type _Release.Author _Release.Detail _Release.Entry_ID 2 . . 2008-07-16 2006-06-28 update BMRB 'complete entry citation' 10022 1 . . 2006-10-26 2006-06-28 original author 'original release' 10022 stop_ loop_ _Related_entries.Database_name _Related_entries.Database_accession_code _Related_entries.Relationship _Related_entries.Entry_ID PDB 2E8D 'BMRB Entry Tracking System' 10022 stop_ save_ ############### # Citations # ############### save_citation_1 _Citation.Sf_category citations _Citation.Sf_framecode citation_1 _Citation.Entry_ID 10022 _Citation.ID 1 _Citation.Class 'entry citation' _Citation.CAS_abstract_code . _Citation.MEDLINE_UI_code . _Citation.DOI . _Citation.PubMed_ID 17108084 _Citation.Full_citation . _Citation.Title ; 3D Structure of amyloid protofibrils of beta2-microglobulin fragment probed by solid-state NMR ; _Citation.Status published _Citation.Type journal _Citation.Journal_abbrev 'Proc. Natl. Acad. Sci. U.S.A.' _Citation.Journal_name_full . _Citation.Journal_volume 103 _Citation.Journal_issue 48 _Citation.Journal_ASTM . _Citation.Journal_ISSN . _Citation.Journal_CSD . _Citation.Book_title . _Citation.Book_chapter_title . _Citation.Book_volume . _Citation.Book_series . _Citation.Book_publisher . _Citation.Book_publisher_city . _Citation.Book_ISBN . _Citation.Conference_title . _Citation.Conference_site . _Citation.Conference_state_province . _Citation.Conference_country . _Citation.Conference_start_date . _Citation.Conference_end_date . _Citation.Conference_abstract_number . _Citation.Thesis_institution . _Citation.Thesis_institution_city . _Citation.Thesis_institution_country . _Citation.WWW_URL . _Citation.Page_first 18119 _Citation.Page_last 18124 _Citation.Year 2006 _Citation.Details . loop_ _Citation_author.Ordinal _Citation_author.Given_name _Citation_author.Family_name _Citation_author.First_initial _Citation_author.Middle_initials _Citation_author.Family_title _Citation_author.Entry_ID _Citation_author.Citation_ID 1 Kentaro Iwata . . . 10022 1 2 Toshimichi Fujiwara . . . 10022 1 3 Yoh Matsuki . . . 10022 1 4 Hideo Akutsu . . . 10022 1 5 Satoshi Takahashi . . . 10022 1 6 Hironobu Naiki . . . 10022 1 7 Yuji Goto . . . 10022 1 stop_ save_ ############################################# # Molecular system (assembly) description # ############################################# save_assembly _Assembly.Sf_category assembly _Assembly.Sf_framecode assembly _Assembly.Entry_ID 10022 _Assembly.ID 1 _Assembly.Name 'K3 peptide of beta2-microglobulin' _Assembly.BMRB_code . _Assembly.Number_of_components 1 _Assembly.Organic_ligands 0 _Assembly.Metal_ions 0 _Assembly.Non_standard_bonds . _Assembly.Ambiguous_conformational_states yes _Assembly.Ambiguous_chem_comp_sites no _Assembly.Molecules_in_chemical_exchange no _Assembly.Paramagnetic no _Assembly.Thiol_state 'all free' _Assembly.Molecular_mass . _Assembly.Enzyme_commission_number . _Assembly.Details . _Assembly.DB_query_date . _Assembly.DB_query_revised_last_date . loop_ _Assembly_type.Type _Assembly_type.Entry_ID _Assembly_type.Assembly_ID 'protein monomer' 10022 1 stop_ loop_ _Entity_assembly.ID _Entity_assembly.Entity_assembly_name _Entity_assembly.Entity_ID _Entity_assembly.Entity_label _Entity_assembly.Asym_ID _Entity_assembly.PDB_chain_ID _Entity_assembly.Experimental_data_reported _Entity_assembly.Physical_state _Entity_assembly.Conformational_isomer _Entity_assembly.Chemical_exchange_state _Entity_assembly.Magnetic_equivalence_group_code _Entity_assembly.Role _Entity_assembly.Details _Entity_assembly.Entry_ID _Entity_assembly.Assembly_ID 1 'K3 peptide of beta2-microglobulin' 1 $K3_peptide_of_beta2-m . . yes unfolded yes no . . . 10022 1 stop_ save_ #################################### # Biological polymers and ligands # #################################### save_K3_peptide_of_beta2-m _Entity.Sf_category entity _Entity.Sf_framecode K3_peptide_of_beta2-m _Entity.Entry_ID 10022 _Entity.ID 1 _Entity.BMRB_code . _Entity.Name 'amyloid protofibrils of beta2-microglobulin fragment' _Entity.Type polymer _Entity.Polymer_common_type . _Entity.Polymer_type polypeptide(L) _Entity.Polymer_type_details . _Entity.Polymer_strand_ID . _Entity.Polymer_seq_one_letter_code_can . _Entity.Polymer_seq_one_letter_code ; SNFLNCYVSGFHPSDIEVDL LK ; _Entity.Target_identifier . _Entity.Polymer_author_defined_seq . _Entity.Polymer_author_seq_details . _Entity.Ambiguous_conformational_states no _Entity.Ambiguous_chem_comp_sites no _Entity.Nstd_monomer no _Entity.Nstd_chirality no _Entity.Nstd_linkage no _Entity.Nonpolymer_comp_ID . _Entity.Nonpolymer_comp_label . _Entity.Number_of_monomers 22 _Entity.Number_of_nonpolymer_components . _Entity.Paramagnetic no _Entity.Thiol_state 'all free' _Entity.Src_method . _Entity.Parent_entity_ID . _Entity.Fragment . _Entity.Mutation . _Entity.EC_number . _Entity.Calc_isoelectric_point . _Entity.Formula_weight . _Entity.Formula_weight_exptl . _Entity.Formula_weight_exptl_meth . _Entity.Details . _Entity.DB_query_date . _Entity.DB_query_revised_last_date 2015-11-26 loop_ _Entity_db_link.Ordinal _Entity_db_link.Author_supplied _Entity_db_link.Database_code _Entity_db_link.Accession_code _Entity_db_link.Entry_mol_code _Entity_db_link.Entry_mol_name _Entity_db_link.Entry_experimental_method _Entity_db_link.Entry_structure_resolution _Entity_db_link.Entry_relation_type _Entity_db_link.Entry_details _Entity_db_link.Chimera_segment_ID _Entity_db_link.Seq_query_to_submitted_percent _Entity_db_link.Seq_subject_length _Entity_db_link.Seq_identity _Entity_db_link.Seq_positive _Entity_db_link.Seq_homology_expectation_val _Entity_db_link.Seq_align_begin _Entity_db_link.Seq_align_end _Entity_db_link.Seq_difference_details _Entity_db_link.Seq_alignment_details _Entity_db_link.Entry_ID _Entity_db_link.Entity_ID 1 no BMRB 15480 . w60g-b2m . . . . . 100.00 100 100.00 100.00 3.76e-06 . . . . 10022 1 2 no BMRB 16587 . "W60G beta2-microglobulin" . . . . . 100.00 100 100.00 100.00 3.76e-06 . . . . 10022 1 3 no BMRB 17165 . WT . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 4 no BMRB 17166 . dN6 . . . . . 100.00 94 100.00 100.00 4.03e-06 . . . . 10022 1 5 no BMRB 19099 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 6 no BMRB 19113 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 7 no BMRB 19116 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 8 no BMRB 19118 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 9 no BMRB 19119 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 10 no BMRB 19120 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 11 no BMRB 19121 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 12 no BMRB 19122 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 13 no BMRB 19123 . human_beta-2_microglobulin . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 14 no BMRB 3078 . microglobulin . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 15 no BMRB 3079 . microglobulin . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 16 no PDB 1A1M . "Mhc Class I Molecule B5301 Complexed With Peptide Tpydinqml From Gag Protein Of Hiv2" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 17 no PDB 1A1N . "Mhc Class I Molecule B3501 Complexed With Peptide Vplrpmty From The Nef Protein (75-82) Of Hiv1" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 18 no PDB 1A1O . "Mhc Class I Molecule B5301 Complexed With Peptide Ls6 (Kpivqydnf) From The Malaria Parasite P. Falciparum" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 19 no PDB 1A6Z . "Hfe (Human) Hemochromatosis Protein" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 20 no PDB 1A9B . "Decamer-Like Conformation Of A Nano-Peptide Bound To Hla- B3501 Due To Nonstandard Positioning Of The C-Terminus" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 21 no PDB 1A9E . "Decamer-Like Conformation Of A Nano-Peptide Bound To Hla- B3501 Due To Nonstandard Positioning Of The C-Terminus" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 22 no PDB 1AGB . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggrkkykl-3r Mutation)" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 23 no PDB 1AGC . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggkkkyql-7q Mutation)" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 24 no PDB 1AGD . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggkkkykl-Index Peptide)" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 25 no PDB 1AGE . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggkkkyrl-7r Mutation)" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 26 no PDB 1AGF . "Antagonist Hiv-1 Gag Peptides Induce Structural Changes In Hla B8-Hiv-1 Gag Peptide (Ggkkrykl-5r Mutation)" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 27 no PDB 1AKJ . "Complex Of The Human Mhc Class I Glycoprotein Hla-A2 And The T Cell Coreceptor Cd8" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 28 no PDB 1AO7 . "Complex Between Human T-Cell Receptor, Viral Peptide (Tax), And Hla-A 0201" . . . . . 100.00 100 100.00 100.00 4.89e-06 . . . . 10022 1 29 no PDB 1B0G . "Class I Histocompatibility Antigen (hla-a2.1)/beta 2- Microglobulin/peptide P1049 Complex" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 30 no PDB 1B0R . "Crystal Structure Of Hla-A0201 Complexed With A Peptide With The Carboxyl-Terminal Group Substituted By A Methyl Group" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 31 no PDB 1BD2 . "Complex Between Human T-Cell Receptor B7, Viral Peptide (Tax) And Mhc Class I Molecule Hla-A 0201" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 32 no PDB 1C16 . "Crystal Structure Analysis Of The GammaDELTA T CELL LIGAND T22" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 33 no PDB 1CE6 . "Mhc Class I H-2db Complexed With A Sendai Virus Nucleoprotein Peptide" . . . . . 100.00 108 100.00 100.00 4.15e-06 . . . . 10022 1 34 no PDB 1CG9 . "Complex Recognition Of The Supertypic Bw6-Determinant On Hla-B And-C Molecules By The Monoclonal Antibody Sfr8-B6" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 35 no PDB 1DE4 . "Hemochromatosis Protein Hfe Complexed With Transferrin Receptor" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 36 no PDB 1DUY . "Crystal Structure Of Hla-A0201OCTAMERIC TAX PEPTIDE Complex" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 37 no PDB 1DUZ . "Human Class I Histocompatibility Antigen (Hla-A 0201) In Complex With A Nonameric Peptide From Htlv-1 Tax Protein" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 38 no PDB 1E27 . "Nonstandard Peptide Binding Of Hla-B5101 Complexed With Hiv Immunodominant Epitope Km1(Lppvvakei)" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 39 no PDB 1E28 . "Nonstandard Peptide Binding Of Hla-B5101 Complexed With Hiv Immunodominant Epitope Km2(Taftipsi)" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 40 no PDB 1EEY . "Crystal Structure Determination Of Hla A2 Complexed To Peptide Gp2 With The Substitution (I2lV5LL9V)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 41 no PDB 1EEZ . "Crystal Structure Determination Of Hla-A2.1 Complexed To Gp2 Peptide Variant(I2lV5L)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 42 no PDB 1EFX . "Structure Of A Complex Between The Human Natural Killer Cell Receptor Kir2dl2 And A Class I Mhc Ligand Hla-Cw3" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 43 no PDB 1EXU . "Crystal Structure Of The Human Mhc-Related Fc Receptor" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 44 no PDB 1GZP . "Cd1b In Complex With Gm2 Ganglioside" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 45 no PDB 1GZQ . "Cd1b In Complex With Phophatidylinositol" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 46 no PDB 1HHG . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 47 no PDB 1HHH . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 48 no PDB 1HHI . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 49 no PDB 1HHJ . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 50 no PDB 1HHK . "The Antigenic Identity Of Peptide(Slash)mhc Complexes: A Comparison Of The Conformation Of Five Peptides Presented By Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 51 no PDB 1HLA . "Structure Of The Human Class I Histocompatibility Antigen, Hla-A2" . . . . . 100.00 97 100.00 100.00 3.59e-06 . . . . 10022 1 52 no PDB 1HSA . "The Three-Dimensional Structure Of Hla-B27 At 2.1 Angstroms Resolution Suggests A General Mechanism For Tight Peptide Binding T" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 53 no PDB 1HSB . "Different Length Peptides Bind To Hla-Aw68 Similarly At Their Ends But Bulge Out In The Middle" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 54 no PDB 1I1F . "Crystal Structure Of Human Class I Mhc (Hla-A2.1) Complexed With Beta 2-Microglobulin And Hiv-Rt Variant Peptide I1y" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 55 no PDB 1I1Y . "Crystal Structure Of Human Class I Mhc (Hla-A2.1) Complexed With Beta 2-Microglobulin And Hiv-Rt Variant Peptide I1y" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 56 no PDB 1I4F . "Crystal Structure Of Hla-A0201MAGE-A4-Peptide Complex" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 57 no PDB 1I7R . "Crystal Structure Of Class I Mhc A2 In Complex With Peptide P1058" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 58 no PDB 1I7T . "Crystal Structure Of Class I Mhc A2 In Complex With Peptide P1049-5v" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 59 no PDB 1I7U . "Crystal Structure Of Class I Mhc A2 In Complex With Peptide P1049-6v" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 60 no PDB 1IM3 . "Crystal Structure Of The Human Cytomegalovirus Protein Us2 Bound To The Mhc Class I Molecule Hla-A2TAX" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 61 no PDB 1IM9 . "Crystal Structure Of The Human Natural Killer Cell Inhibitory Receptor Kir2dl1 Bound To Its Mhc Ligand Hla-Cw4" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 62 no PDB 1JF1 . "Crystal Structure Of Hla-A20201 In Complex With A Decameric Altered Peptide Ligand From The Mart-1MELAN-A" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 63 no PDB 1JGD . "Hla-B2709 Bound To Deca-Peptide S10r" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 64 no PDB 1JGE . "Hla-B2705 Bound To Nona-Peptide M9" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 65 no PDB 1JHT . "Crystal Structure Of Hla-A20201 In Complex With A Nonameric Altered Peptide Ligand (Algigiltv) From The Mart- 1MELAN-A." . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 66 no PDB 1JNJ . "Nmr Solution Structure Of The Human Beta2-Microglobulin" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 67 no PDB 1K5N . "Hla-B2709 Bound To Nona-Peptide M9" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 68 no PDB 1KPR . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla-E" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 69 no PDB 1KTL . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla-E" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 70 no PDB 1LDS . "Crystal Structure Of Monomeric Human Beta-2-Microglobulin" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 71 no PDB 1LP9 . "Xenoreactive Complex Ahiii 12.2 Tcr Bound To P1049HLA-A2.1" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 72 no PDB 1M05 . "Hla B8 In Complex With An Epstein Barr Virus Determinant" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 73 no PDB 1M6O . "Crystal Structure Of Hla B4402 In Complex With Hla Dpa0201 Peptide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 74 no PDB 1MHE . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla-E" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 75 no PDB 1MI5 . "The Crystal Structure Of Lc13 Tcr In Complex With Hlab8-Ebv Peptide Complex" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 76 no PDB 1N2R . "A Natural Selected Dimorphism In Hla B44 Alters Self, Peptide Reportoire And T Cell Recognition." . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 77 no PDB 1OF2 . "Crystal Structure Of Hla-B2709 Complexed With The Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Peptide (Residues 400-40" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 78 no PDB 1OGA . "A Structural Basis For Immunodominant Human T-Cell Receptor Recognition." . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 79 no PDB 1OGT . "Crystal Structure Of Hla-B2705 Complexed With The Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Peptide (Residues 400-40" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 80 no PDB 1ONQ . "Crystal Structure Of Cd1a In Complex With A Sulfatide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 81 no PDB 1P7Q . "Crystal Structure Of Hla-A2 Bound To Lir-1, A Host And Viral Mhc Receptor" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 82 no PDB 1Q94 . "Structures Of Hla-A1101 In Complex With Immunodominant Nonamer And Decamer Hiv-1 Epitopes Clearly Reveal The Presence Of A Midd" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 83 no PDB 1QEW . "Human Class I Histocompatibility Antigen (Hla-A 0201) Complex With A Nonameric Peptide From Melanoma-Associated Antigen 3 (Resi" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 84 no PDB 1QLF . "Mhc Class I H-2db Complexed With Glycopeptide K3g" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 85 no PDB 1QQD . "Crystal Structure Of Hla-Cw4, A Ligand For The Kir2d Natural Killer Cell Inhibitory Receptor" . . . . . 100.00 99 100.00 100.00 4.04e-06 . . . . 10022 1 86 no PDB 1QR1 . "Poor Binding Of A Her-2NEU EPITOPE (GP2) TO HLA-A2.1 Is Due To A Lack Of Interactions In The Center Of The Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 87 no PDB 1QRN . "Crystal Structure Of Human A6 Tcr Complexed With Hla-A2 Bound To Altered Htlv-1 Tax Peptide P6a" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 88 no PDB 1QSE . "Structure Of Human A6-Tcr Bound To Hla-A2 Complexed With Altered Htlv-1 Tax Peptide V7r" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 89 no PDB 1QSF . "Structure Of A6-Tcr Bound To Hla-A2 Complexed With Altered Htlv-1 Tax Peptide Y8a" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 90 no PDB 1QVO . "Structures Of Hla-A1101 In Complex With Immunodominant Nonamer And Decamer Hiv-1 Epitopes Clearly Reveal The Presence Of A Midd" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 91 no PDB 1R3H . "Crystal Structure Of T10" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 92 no PDB 1S8D . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-3a" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 93 no PDB 1S9W . "Crystal Structure Analysis Of Ny-eso-1 Epitope, Sllmwitqc, In Complex With Hla-a2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 94 no PDB 1S9X . "Crystal Structure Analysis Of Ny-Eso-1 Epitope Analogue, Sllmwitqa, In Complex With Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 95 no PDB 1S9Y . "Crystal Structure Analysis Of Ny-Eso-1 Epitope Analogue, Sllmwitqs, In Complex With Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 96 no PDB 1SYS . "Crystal Structure Of Hla, B4403, And Peptide Eeptvikky" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 97 no PDB 1SYV . "Hla-B4405 Complexed To The Dominant Self Ligand Eefgraygf" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 98 no PDB 1T1W . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-3f6i8v" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 99 no PDB 1T1X . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-4l" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 100 no PDB 1T1Y . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-5v" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 101 no PDB 1T1Z . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-6a" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 102 no PDB 1T20 . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9-6i" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 103 no PDB 1T21 . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9, Monoclinic Crystal" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 104 no PDB 1T22 . "Structural Basis For Degenerate Recognition Of Hiv Peptide Variants By Cytotoxic Lymphocyte, Variant Sl9, Orthorhombic Crystal" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 105 no PDB 1TMC . "The Three-Dimensional Structure Of A Class I Major Histocompatibility Complex Molecule Missing The Alpha3 Domain Of The Heavy C" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 106 no PDB 1TVB . "Crystal Structure Of Melanoma Antigen Gp100(209-217) Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 107 no PDB 1TVH . "Crystal Structure Of Modified Melanoma Antigen Gp100(209-T2m) Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 108 no PDB 1UQS . "The Crystal Structure Of Human Cd1b With A Bound Bacterial Glycolipid" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 109 no PDB 1UXS . "Crystal Structure Of Hla-B2705 Complexed With The Latent Membrane Protein 2 Peptide (Lmp2)of Epstein-Barr Virus" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 110 no PDB 1UXW . "Crystal Structure Of Hla-B2709 Complexed With The Latent Membrane Protein 2 Peptide (Lmp2) Of Epstein-Barr Virus" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 111 no PDB 1VGK . "The Crystal Structure Of Class I Major Histocompatibility Complex, H-2kd At 2.0 A Resolution" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 112 no PDB 1W0V . "Crystal Structure Of Hla-B2705 Complexed With The Self-Peptide Tis From Egf-Response Factor 1" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 113 no PDB 1W0W . "Crystal Structure Of Hla-B2709 Complexed With The Self-Peptide Tis From Egf-Response Factor 1" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 114 no PDB 1W72 . "Crystal Structure Of Hla-A1:mage-A1 In Complex With Fab- Hyb3" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 115 no PDB 1X7Q . "Crystal Structure Of Hla-A1101 With Sars Nucleocapsid Peptide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 116 no PDB 1XH3 . "Conformational Restraints And Flexibility Of 14-Meric Peptides In Complex With Hla-B3501" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 117 no PDB 1XR8 . "Crystal Structures Of Hla-B1501 In Complex With Peptides From Human Ubch6 And Epstein-Barr Virus Ebna-3" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 118 no PDB 1XR9 . "Crystal Structures Of Hla-B1501 In Complex With Peptides From Human Ubch6 And Epstein-Barr Virus Ebna-3" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 119 no PDB 1XZ0 . "Crystal Structure Of Cd1a In Complex With A Synthetic Mycobactin Lipopeptide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 120 no PDB 1YDP . "1.9a Crystal Structure Of Hla-G" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 121 no PDB 1YPZ . "Immune Receptor" . . . . . 100.00 102 100.00 100.00 3.86e-06 . . . . 10022 1 122 no PDB 1ZHK . "Crystal Structure Of Hla-b*3501 Presenting 13-mer Ebv Antigen Lpeplpqgqltay" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 123 no PDB 1ZHL . "Crystal Structure Of Hla-b*3508 Presenting 13-mer Ebv Antigen Lpeplpqgqltay" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 124 no PDB 1ZS8 . "Crystal Structure Of The Murine Mhc Class Ib Molecule M10.5" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 125 no PDB 1ZSD . "Crystal Structure Of Hla-B3501 Presenting An 11-Mer Ebv Antigen Eplpqgqltay" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 126 no PDB 1ZT4 . "The Crystal Structure Of Human Cd1d With And Without Alpha- Galactosylceramide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 127 no PDB 1ZVS . "Crystal Structure Of The First Class Mhc Mamu And Tat-Tl8 Complex" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 128 no PDB 2A83 . "Crystal Structure Of Hla-B2705 Complexed With The Glucagon Receptor (Gr) Peptide (Residues 412-420)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 129 no PDB 2AK4 . "Crystal Structure Of Sb27 Tcr In Complex With Hla-B3508- 13mer Peptide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 130 no PDB 2AV1 . "Crystal Structure Of Htlv-1 Tax Peptide Bound To Human Class I Mhc Hla-A2 With The E63q And K66a Mutations In The Heavy Chain." . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 131 no PDB 2AV7 . "Crystal Structure Of Htlv-1 Tax Peptide Bound To Human Class I Mhc Hla-A2 With The K66a Mutation In The Heavy Chain." . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 132 no PDB 2AXF . "The Immunogenicity Of A Viral Cytotoxic T Cell Epitope Is Controlled By Its Mhc-Bound Conformation" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 133 no PDB 2AXG . "The Immunogenicity Of A Viral Cytotoxic T Cell Epitope Is Controlled By Its Mhc-Bound Conformation" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 134 no PDB 2BCK . "Crystal Structure Of Hla-A2402 Complexed With A Telomerase Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 135 no PDB 2BNQ . "Structural And Kinetic Basis For Heightened Immunogenicity Of T Cell Vaccines" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 136 no PDB 2BNR . "Structural And Kinetic Basis For Heightened Immunogenicity Of T Cell Vaccines" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 137 no PDB 2BSR . "Crystal Structures And Kir3dl1 Recognition Of Three Immunodominant Viral Peptides Complexed To Hla-B2705" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 138 no PDB 2BSS . "Crystal Structures And Kir3dl1 Recognition Of Three Immunodominant Viral Peptides Complexed To Hla-B2705" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 139 no PDB 2BST . "Crystal Structures And Kir3dl1 Recognition Of Three Immunodominant Viral Peptides Complexed To Hla-b2705" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 140 no PDB 2BVO . "Structures Of Three Hiv-1 Hla-B5703-Peptide Complexes And Identification Of Related Hlas Potentially Associated With Long-Term " . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 141 no PDB 2BVP . "Structures Of Three Hiv-1 Hla-B5703-Peptide Complexes And Identification Of Related Hlas Potentially Associated With Long-Term " . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 142 no PDB 2BVQ . "Structures Of Three Hiv-1 Hla-B5703-Peptide Complexes And Identification Of Related Hlas Potentially Associated With Long-Term " . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 143 no PDB 2C7U . "Conflicting Selective Forces Affect Cd8 T-Cell Receptor Contact Sites In An Hla-A2 Immunodominant Hiv Epitope." . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 144 no PDB 2CII . "The Crystal Structure Of H-2db Complexed With A Partial Peptide Epitope Suggests An Mhc Class I Assembly- Intermediate" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 145 no PDB 2CIK . "Insights Into Crossreactivity In Human Allorecognition: The Structure Of Hla-B35011 Presenting An Epitope Derived From Cytochro" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 146 no PDB 2CLR . "Three Dimensional Structure Of A Peptide Extending Out One End Of A Class I Mhc Binding Site" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 147 no PDB 2D31 . "Crystal Structure Of Disulfide-Linked Hla-G Dimer" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 148 no PDB 2D4F . "The Crystal Structure Of Human Beta2-Microglobulin" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 149 no PDB 2DYP . "Crystal Structure Of Lilrb2(Lir2ILT4CD85D) COMPLEXED WITH Hla-G" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 150 no PDB 2E8D . "3d Structure Of Amyloid Protofilaments Of Beta2- Microglobulin Fragment Probed By Solid-State Nmr" . . . . . 100.00 22 100.00 100.00 4.72e-06 . . . . 10022 1 151 no PDB 2ESV . "Structure Of The Hla-E-VmaprtlilKK50.4 TCR COMPLEX" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 152 no PDB 2F53 . "Directed Evolution Of Human T-Cell Receptor Cdr2 Residues By Phage Display Dramatically Enhances Affinity For Cognate Peptide-M" . . . . . 100.00 100 100.00 100.00 4.51e-06 . . . . 10022 1 153 no PDB 2F54 . "Directed Evolution Of Human T Cell Receptor Cdr2 Residues By Phage Display Dramatically Enhances Affinity For Cognate Peptide-M" . . . . . 100.00 100 100.00 100.00 4.89e-06 . . . . 10022 1 154 no PDB 2F74 . "Murine Mhc Class I H-2db In Complex With Human B2-Microglobulin And Lcmv-Derived Immunodminant Peptide Gp33" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 155 no PDB 2FYY . "The Role Of T Cell Receptor Alpha Genes In Directing Human Mhc Restriction" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 156 no PDB 2FZ3 . "The Role Of T Cell Receptor Alpha Genes In Directing Human Mhc Restriction" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 157 no PDB 2GIT . "Human Class I Mhc Hla-A2 In Complex With The Modified Htlv-1 Tax (Y5k- 4-[3-Indolyl]-Butyric Acid) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 158 no PDB 2GJ6 . "The Complex Between Tcr A6 And Human Class I Mhc Hla-a2 With The Modified Htlv-1 Tax (y5k-4-[3-indolyl]-butyric Acid) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 159 no PDB 2GT9 . "Human Class I Mhc Hla-A2 In Complex With The Decameric Melan-AMART- 1(26-35) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 160 no PDB 2GTW . "Human Class I Mhc Hla-A2 In Complex With The Nonameric Melan-AMART- 1(27-35) Peptide Having A27l Substitution" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 161 no PDB 2GTZ . "Human Class I Mhc Hla-A2 In Complex With The Nonameric Melan-AMART- 1(27-35) Peptide Having A28l Substitution" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 162 no PDB 2GUO . "Human Class I Mhc Hla-A2 In Complex With The Native Nonameric Melan- AMART-1(27-35) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 163 no PDB 2H26 . "Human Cd1b In Complex With Endogenous Phosphatidylcholine And Spacer" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 164 no PDB 2H6P . "Crystal Structure Of Hla-B3501 Presenting The Human Cytochrome P450 Derived Peptide, Kpivvlhgy" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 165 no PDB 2HJK . "Crystal Structure Of Hla-B5703 And Hiv-1 Peptide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 166 no PDB 2HJL . "Crystal Structure Of Hla-B5703 And Hiv-1 Peptide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 167 no PDB 2HLA . "Specificity Pockets For The Side Chains Of Peptide Antigens In Hla-Aw68" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 168 no PDB 2HN7 . "Hla-A1101 In Complex With Hbv Peptide Homologue" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 169 no PDB 2J8U . "Large Cdr3a Loop Alteration As A Function Of Mhc Mutation." . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 170 no PDB 2JCC . "Ah3 Recognition Of Mutant Hla-A2 W167a" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 171 no PDB 2NW3 . "Crystal Structure Of Hla-B3508 Presenting Ebv Peptide Eplpqgqltay At 1.7a" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 172 no PDB 2NX5 . "Crystal Structure Of Els4 Tcr Bound To Hla-B3501 Presenting Peptide Eplpqgqltay At 1.7a" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 173 no PDB 2P5E . "Crystal Structures Of High Affinity Human T-Cell Receptors Bound To Pmhc Reveal Native Diagonal Binding Geometry" . . . . . 100.00 100 100.00 100.00 4.51e-06 . . . . 10022 1 174 no PDB 2P5W . "Crystal Structures Of High Affinity Human T-Cell Receptors Bound To Pmhc Reveal Native Diagonal Binding Geometry" . . . . . 100.00 100 100.00 100.00 4.51e-06 . . . . 10022 1 175 no PDB 2PO6 . "Crystal Structure Of Cd1d-lipid-antigen Complexed With Beta-2- Microglobulin, Nkt15 Alpha-chain And Nkt15 Beta-chain" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 176 no PDB 2PYE . "Crystal Structures Of High Affinity Human T-Cell Receptors Bound To Pmhc Revealnative Diagonal Binding Geometry Tcr Clone C5c1 " . . . . . 100.00 100 100.00 100.00 4.51e-06 . . . . 10022 1 177 no PDB 2RFX . "Crystal Structure Of Hla-B5701, Presenting The Self Peptide, Lsspvtksf" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 178 no PDB 2UWE . "Large Cdr3a Loop Alteration As A Function Of Mhc Mutation" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 179 no PDB 2V2W . "T Cell Cross-Reactivity And Conformational Changes During Tcr Engagement" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 180 no PDB 2V2X . "T Cell Cross-Reactivity And Conformational Changes During Tcr Engagement." . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 181 no PDB 2VB5 . "Solution Structure Of W60g Mutant Of Human Beta2- Microglobulin" . . . . . 100.00 100 100.00 100.00 3.76e-06 . . . . 10022 1 182 no PDB 2VLJ . "The Structural Dynamics And Energetics Of An Immunodominant T-Cell Receptor Are Programmed By Its Vbeta Domain" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 183 no PDB 2VLK . "The Structural Dynamics And Energetics Of An Immunodominant T-Cell Receptor Are Programmed By Its Vbeta Domain" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 184 no PDB 2VLL . "The Structural Dynamics And Energetics Of An Immunodominant T-Cell Receptor Are Programmed By Its Vbeta Domain" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 185 no PDB 2VLR . "The Structural Dynamics And Energetics Of An Immunodominant T-cell Receptor Are Programmed By Its Vbeta Domain" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 186 no PDB 2X4N . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Residual Fragments Of A Photocleavable Peptide That Is Cleaved Upon Uv-Light" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 187 no PDB 2X4O . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Hiv-1 Envelope Peptide Env120-128" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 188 no PDB 2X4P . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Photocleavable Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 189 no PDB 2X4Q . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Photocleavable Peptide" . . . . . 100.00 100 100.00 100.00 3.84e-06 . . . . 10022 1 190 no PDB 2X4R . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Cytomegalovirus (Cmv) Pp65 Epitope" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 191 no PDB 2X4S . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Peptide Representing The Epitope Of The H5n1 (Avian Flu) Nucleoprotein" . . . . . 100.00 100 100.00 100.00 3.84e-06 . . . . 10022 1 192 no PDB 2X4T . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Peiodate-Cleavable Peptide" . . . . . 100.00 100 100.00 100.00 3.84e-06 . . . . 10022 1 193 no PDB 2X4U . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Hiv-1 Peptide Rt468-476" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 194 no PDB 2X70 . "Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A Photocleavable Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 195 no PDB 2X89 . "Structure Of The Beta2_microglobulin Involved In Amyloidogenesis" . . . . . 100.00 94 100.00 100.00 4.03e-06 . . . . 10022 1 196 no PDB 2XKS . "Prion-Like Conversion During Amyloid Formation At Atomic Resolution" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 197 no PDB 2XKU . "Prion-Like Conversion During Amyloid Formation At Atomic Resolution" . . . . . 100.00 94 100.00 100.00 4.03e-06 . . . . 10022 1 198 no PDB 2XPG . "Crystal Structure Of A Mhc Class I-Peptide Complex" . . . . . 100.00 98 100.00 100.00 3.41e-06 . . . . 10022 1 199 no PDB 2YPK . "Structural Features Underlying T-cell Receptor Sensitivity To Concealed Mhc Class I Micropolymorphisms" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 200 no PDB 2YPL . "Structural Features Underlying T-cell Receptor Sensitivity To Concealed Mhc Class I Micropolymorphisms" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 201 no PDB 2YXF . "The High Resolution Crystal Structure Of Beta2- Microglobulin Under Physiological Conditions" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 202 no PDB 2Z9T . "Crystal Structure Of The Human Beta-2 Microglobulin Mutant W60g" . . . . . 100.00 100 100.00 100.00 3.76e-06 . . . . 10022 1 203 no PDB 3AM8 . "Crystal Structure Of A Human Major Histocompatibilty Complex" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 204 no PDB 3B3I . "Citrullination-dependent Differential Presentation Of A Self-peptide By Hla-b27 Subtypes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 205 no PDB 3B6S . "Crystal Structure Of Hla-B2705 Complexed With The Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Peptide (R" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 206 no PDB 3BGM . "Crystal Structure Of Pkd2 Phosphopeptide Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 207 no PDB 3BH8 . "Crystal Structure Of Rqa_m Phosphopeptide Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 208 no PDB 3BH9 . "Crystal Structure Of Rty Phosphopeptide Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 209 no PDB 3BHB . "Crystal Structure Of Kmd Phosphopeptide Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 98 100.00 100.00 3.55e-06 . . . . 10022 1 210 no PDB 3BO8 . "The High Resolution Crystal Structure Of Hla-A1 Complexed With The Mage-A1 Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 211 no PDB 3BP4 . "The High Resolution Crystal Structure Of Hla-B2705 In Complex With A Cathepsin A Signal Sequence Peptide Pcata" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 212 no PDB 3BP7 . "The High Resolution Crystal Structure Of Hla-b*2709 In Complex With A Cathepsin A Signal Sequence Peptide, Pcata" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 213 no PDB 3BVN . "High Resolution Crystal Structure Of Hla-B1402 In Complex With The Latent Membrane Protein 2 Peptide (Lmp2) Of Epstein-Barr Vir" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 214 no PDB 3BW9 . "Crystal Structure Of Hla B3508 In Complex With A Hcmv 12- Mer Peptide From The Pp65 Protein" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 215 no PDB 3BWA . "Crystal Structure Of Hla B3508 In Complex With A Hcmv 8- Mer Peptide From The Pp65 Protein" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 216 no PDB 3BXN . "The High Resolution Crystal Structure Of Hla-b*1402 Complexed With A Cathepsin A Signal Sequence Peptide, Pcata" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 217 no PDB 3BZE . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla- E" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 218 no PDB 3BZF . "The Human Non-Classical Major Histocompatibility Complex Molecule Hla-E" . . . . . 100.00 97 100.00 100.00 3.78e-06 . . . . 10022 1 219 no PDB 3C9N . "Crystal Structure Of A Sars Corona Virus Derived Peptide Bound To The Human Major Histocompatibility Complex Class I Molecule H" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 220 no PDB 3CDG . "Human Cd94NKG2A IN COMPLEX WITH HLA-E" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 221 no PDB 3CII . "Structure Of Nkg2aCD94 BOUND TO HLA-E" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 222 no PDB 3CIQ . "A Regulatable Switch Mediates Self-Association In An Immunoglobulin Fold" . . . . . 100.00 100 100.00 100.00 3.43e-06 . . . . 10022 1 223 no PDB 3CZF . "Crystal Structure Of Hla-B2709 Complexed With The Glucagon Receptor (Gr) Peptide (Residues 412-420)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 224 no PDB 3D18 . "Crystal Structure Of Hla-B2709 Complexed With A Variant Of The Latent Membrane Protein 2 Peptide (Lmp2(L)) Of Epstein-Barr Viru" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 225 no PDB 3D25 . "Crystal Structure Of Ha-1 Minor Histocompatibility Antigen Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 98 100.00 100.00 3.55e-06 . . . . 10022 1 226 no PDB 3D2U . "Structure Of Ul18, A Peptide-binding Viral Mhc Mimic, Bound To A Host Inhibitory Receptor" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 227 no PDB 3D39 . "The Complex Between Tcr A6 And Human Class I Mhc Hla-A2 With The Modified Htlv-1 Tax (Y5(4-Fluorophenylalanine)) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 228 no PDB 3D3V . "The Complex Between Tcr A6 And Human Class I Mhc Hla-a2 With The Modified Htlv-1 Tax (y5(3,4-difluorophenylalanine)) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 229 no PDB 3DBX . "Structure Of Chicken Cd1-2 With Bound Fatty Acid" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 230 no PDB 3DHJ . "Beta 2 Microglobulin Mutant W60c" . . . . . 100.00 100 100.00 100.00 4.29e-06 . . . . 10022 1 231 no PDB 3DHM . "Beta 2 Microglobulin Mutant D59p" . . . . . 100.00 100 100.00 100.00 3.47e-06 . . . . 10022 1 232 no PDB 3DTX . "Crystal Structure Of Hla-B2705 Complexed With The Double Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Pep" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 233 no PDB 3DX6 . "Crystal Structure Of B4402 Presenting A 10mer Ebv Epitope" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 234 no PDB 3DX7 . "Crystal Structure Of Hla-B4403 Presenting 10mer Ebv Antigen" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 235 no PDB 3DX8 . "Crystal Structure Of B4405 Presenting A 10mer Ebv Epitope" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 236 no PDB 3DXA . "Crystal Structure Of The Dm1 Tcr In Complex With Hla-B4405 And Decamer Ebv Antigen" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 237 no PDB 3EKC . "Structure Of W60v Beta-2 Microglobulin Mutant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 238 no PDB 3FFC . "Crystal Structure Of Cf34 Tcr In Complex With Hla-b8/flr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 239 no PDB 3FQN . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 100.00 98 100.00 100.00 3.55e-06 . . . . 10022 1 240 no PDB 3FQR . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 100.00 98 100.00 100.00 3.55e-06 . . . . 10022 1 241 no PDB 3FQT . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 100.00 98 100.00 100.00 3.55e-06 . . . . 10022 1 242 no PDB 3FQU . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 100.00 98 100.00 100.00 3.55e-06 . . . . 10022 1 243 no PDB 3FQW . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 100.00 98 100.00 100.00 3.55e-06 . . . . 10022 1 244 no PDB 3FQX . "Phosphorylation Of Self-Peptides Alters Human Leukocyte Antigen Class I-Restricted Antigen Presentation And Generates Tumor Spe" . . . . . 100.00 98 100.00 100.00 3.55e-06 . . . . 10022 1 245 no PDB 3FT2 . "Crystal Structure Of A Citrulline Peptide Variant Of The Minor Histocompatibility Peptide Ha-1 In Complex With Hla- A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 246 no PDB 3FT3 . "Crystal Structure Of The Minor Histocompatibility Peptide Ha-1his In Complex With Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 247 no PDB 3FT4 . "Crystal Structure Of The Minor Histocompatibility Peptide Ha-1arg In Complex With Hla-A2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 248 no PDB 3GIV . "Antigen Processing Influences Hiv-Specific Cytotoxic T Lymphocyte Immunodominance" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 249 no PDB 3GJF . "Rational Development Of High-Affinity T-Cell Receptor-Like Antibodies" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 250 no PDB 3GSN . "Crystal Structure Of The Public Ra14 Tcr In Complex With The Hcmv Dominant NlvHLA-A2 Epitope" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 251 no PDB 3GSO . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 252 no PDB 3GSQ . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-M5s Peptide Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 253 no PDB 3GSR . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-M5v Peptide Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 254 no PDB 3GSU . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-M5t Peptide Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 255 no PDB 3GSV . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-M5q Peptide Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 256 no PDB 3GSW . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-T8a Peptide Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 257 no PDB 3GSX . "Crystal Structure Of The Binary Complex Between Hla-A2 And Hcmv Nlv-T8v Peptide Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 258 no PDB 3H7B . "Human Class I Mhc Hla-a2 In Complex With The Tel1p Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 259 no PDB 3H9H . "Human Class I Mhc Hla-A2(A150p) In Complex With The Tel1p Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 260 no PDB 3H9S . "The Complex Between Tcr A6 And Human Class I Mhc Hla-A2 With The Bound Tel1p Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 261 no PDB 3HAE . "Rational Development Of High-Affinity T-Cell Receptor-Like Antibodies" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 262 no PDB 3HCV . "Crystal Structure Of Hla-B2709 Complexed With The Double Citrullinated Vasoactive Intestinal Peptide Type 1 Receptor (Vipr) Pep" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 263 no PDB 3HG1 . "Germline-governed Recognition Of A Cancer Epitope By An Immunodominant Human T Cell Receptor" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 264 no PDB 3HLA . "Human Class I Histocompatibility Antigen A2.1" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 265 no PDB 3HPJ . "Human Class I Mhc Hla-a2 In Complex With The Wt-1 (126-134) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 266 no PDB 3HUJ . "Crystal Structure Of Human Cd1d-Alpha-Galactosylceramide In Complex With Semi-Invariant Nkt Cell Receptor" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 267 no PDB 3I6G . "Newly Identified Epitope Mn2 From Sars-Cov M Protein Complexed Withhla-A0201" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 268 no PDB 3I6K . "Newly Identified Epitope From Sars-Cov Membrane Protein Complexed With Hla-A0201" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 269 no PDB 3I6L . "Newly Identified Epitope N1 Derived From Sars-Cov N Protein Complexed With Hla-A2402" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 270 no PDB 3IB4 . "The Double Mutant Of Beta-2 Microglobulin K58p-W60g" . . . . . 100.00 100 100.00 100.00 3.33e-06 . . . . 10022 1 271 no PDB 3IXA . "Human Class I Mhc Hla-A2(A150p) In Complex With The Tax Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 272 no PDB 3JTS . Gy9-Mamu-A02-Hb2m . . . . . 100.00 119 100.00 100.00 2.97e-06 . . . . 10022 1 273 no PDB 3JTT . "Cystal Structure Of Rhesus Macaque Mhc Class I:mamu-A02" . . . . . 95.45 100 100.00 100.00 1.65e-05 . . . . 10022 1 274 no PDB 3KLA . "Ca2+ Release From The Endoplasmic Reticulum Of Ny-Eso-1 Specific T Cells Is Modulated By The Affinity Of T Cell Receptor And By" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 275 no PDB 3KPL . "Crystal Structure Of Hla B4402 In Complex With Eeylqafty A Self Peptide From The Abcd3 Protein" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 276 no PDB 3KPM . "Crystal Structure Of Hla B4402 In Complex With Eeylkawtf, A Mimotope" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 277 no PDB 3KPN . "Crystal Structure Of Hla B4403 In Complex With Eeylqafty A Self Peptide From The Abcd3 Protein" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 278 no PDB 3KPO . "Crystal Structure Of Hla B*4403 In Complex With Eeylkawtf, A Mimotope" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 279 no PDB 3KPP . "Crystal Structure Of Hla B4405 In Complex With Eeylqafty A Self Peptide From The Abcd3 Protein" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 280 no PDB 3KPQ . "Crystal Structure Of Hla B*4405 In Complex With Eeylkawtf, A Mimotope" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 281 no PDB 3KPR . "Crystal Structure Of The Lc13 Tcr In Complex With Hla B4405 Bound To Eeylkawtf A Mimotope" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 282 no PDB 3KPS . "Crystal Structure Of The Lc13 Tcr In Complex With Hla B4405 Bound To Eeylqafty A Self Peptide From The Abcd3 Protein" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 283 no PDB 3KWW . "Crystal Structure Of The 'restriction Triad' Mutant Of Hla B Beta-2-Microglobulin And Ebv Peptide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 284 no PDB 3KXF . "Crystal Structure Of Sb27 Tcr In Complex With The 'restriction Triad' Mutant Hla-b*3508-13mer" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 285 no PDB 3KYN . "Crystal Structure Of Hla-g Presenting Kgppaaltl Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 286 no PDB 3KYO . "Crystal Structure Of Hla-g Presenting Klpaqfyil Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 287 no PDB 3L3D . "Crystal Structure Of Hla-b*4402 In Complex With The F3a Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 288 no PDB 3L3G . "Crystal Structure Of Hla-b*4402 In Complex With The R5a Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 289 no PDB 3L3I . "Crystal Structure Of Hla-b*4402 In Complex With The F7a Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 290 no PDB 3L3J . "Crystal Structure Of Hla-b*4402 In Complex With The F3a/r5a Double Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 291 no PDB 3L3K . "Crystal Structure Of Hla-b*4402 In Complex With The R5a/f7a Double Mutant Of A Self-peptide Derived From Dpa*0201" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 292 no PDB 3LKN . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1918 Strain" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 293 no PDB 3LKO . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1934 Strain" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 294 no PDB 3LKP . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1972 Strain" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 295 no PDB 3LKQ . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1977 Strain" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 296 no PDB 3LKR . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 2009 H1n1 Swine Origin Strain" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 297 no PDB 3LKS . "Crystal Structure Of Hla B3501 In Complex With Influenza Np418 Epitope From 1980 Strain" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 298 no PDB 3LN4 . "Crystal Structure Of Hla-B4103 In Complex With A 16mer Self-Peptide Derived From Heterogeneous Nuclear Ribonucleoproteins C1C2" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 299 no PDB 3LN5 . "Crystal Structure Of Hla-B4104 In Complex With A 11mer Self-Peptide Derived From S-Methyl-5-Thioadenosine Phosphorylase" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 300 no PDB 3LOW . "Crystal Structure Of Beta 2 Microglobulin Domain-Swapped Dimer" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 301 no PDB 3LV3 . "Crystal Structure Of Hla-B2705 Complexed With A Peptide Derived From The Human Voltage-Dependent Calcium Channel Alpha1 Subunit" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 302 no PDB 3M17 . "Crystal Structure Of Human Fcrn With A Monomeric Peptide Inhibitor" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 303 no PDB 3M1B . "Crystal Structure Of Human Fcrn With A Dimeric Peptide Inhibitor" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 304 no PDB 3MGO . "Crystal Structure Of A H5-Specific Ctl Epitope Derived From Influenza Virus In Complex With Hla-A0201" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 305 no PDB 3MGT . "Crystal Structure Of A H5-Specific Ctl Epitope Variant Deriv H5n1 Influenza Virus In Complex With Hla-A0201" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 306 no PDB 3MR9 . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcmv Pp65-495-503 Nonapeptide M5a Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 307 no PDB 3MRB . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcmv Pp65-495-503 Nonapeptide A7h Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 308 no PDB 3MRC . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcmv Pp65-495-503 Nonapeptide V6c Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 309 no PDB 3MRD . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcmv Pp65-495-503 Nonapeptide V6g Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 310 no PDB 3MRE . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Ebv Bmlf1-280-288 Nonapeptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 311 no PDB 3MRF . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Ebv Bmlf1-280-288 Nonapeptide T4p Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 312 no PDB 3MRG . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 313 no PDB 3MRH . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide N3s Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 314 no PDB 3MRI . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide G4m-V5w Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 315 no PDB 3MRJ . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide V5m Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 316 no PDB 3MRK . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Afp137 Nonapeptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 317 no PDB 3MRL . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Hcv Ns3-1073-1081 Nonapeptide C6v Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 318 no PDB 3MRM . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcv Ns3-1406-1415 Decapeptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 319 no PDB 3MRN . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Hcv Ns4b-1807-1816 Decapeptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 320 no PDB 3MRO . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Melan- A Mart1 Decapeptide Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 321 no PDB 3MRP . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Melan- A Mart1 Decapeptide Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 322 no PDB 3MRQ . "Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed With Melan- A Mart1 Decapeptide Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 323 no PDB 3MRR . "Crystal Structure Of Mhc Class I Hla-a2 Molecule Complexed With Human Prostaglandin Transporter Decapeptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 324 no PDB 3MV7 . "Crystal Structure Of The Tk3 Tcr In Complex With Hla-B3501HPVG" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 325 no PDB 3MV8 . "Crystal Structure Of The Tk3-Gln55his Tcr In Complex With Hla- B3501HPVG" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 326 no PDB 3MV9 . "Crystal Structure Of The Tk3-Gln55ala Tcr In Complex With Hla- B3501HPVG" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 327 no PDB 3MYJ . "Human Class I Mhc Hla-a2 In Complex With The Wt-1 (126-134) (r1y) Peptide Variant." . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 328 no PDB 3MYZ . "Protein Induced Photophysical Changes To The Amyloid Indicator Dye, Thioflavin T" . . . . . 100.00 100 100.00 100.00 3.43e-06 . . . . 10022 1 329 no PDB 3MZT . "Protein-Induced Photophysical Changes To The Amyloid Indicator Dye, Thioflavin T" . . . . . 100.00 100 100.00 100.00 3.43e-06 . . . . 10022 1 330 no PDB 3NFN . "Recognition Of Peptide-mhc By A V-delta/v-beta Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 331 no PDB 3O3A . "Human Class I Mhc Hla-A2 In Complex With The Peptidomimetic Ela-1" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 332 no PDB 3O3B . "Human Class I Mhc Hla-A2 In Complex With The Peptidomimetic Ela-1.1" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 333 no PDB 3O3D . "Human Class I Mhc Hla-A2 In Complex With The Peptidomimetic Ela-2" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 334 no PDB 3O3E . "Human Class I Mhc Hla-A2 In Complex With The Peptidomimetic Ela-2.1" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 335 no PDB 3O4L . "Genetic And Structural Basis For Selection Of A Ubiquitous T Cell Receptor Deployed In Epstein-barr Virus" . . . . . 100.00 100 100.00 100.00 4.51e-06 . . . . 10022 1 336 no PDB 3OV6 . "Cd1c In Complex With Mpm (Mannosyl-Beta1-Phosphomycoketide)" . . . . . 100.00 397 100.00 100.00 2.52e-06 . . . . 10022 1 337 no PDB 3OX8 . "Crystal Structure Of Hla A02:03 Bound To Hbv Core 18-27" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 338 no PDB 3OXR . "Crystal Structure Of Hla A02:06 Bound To Hbv Core 18-27" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 339 no PDB 3OXS . "Crystal Structure Of Hla A02:07 Bound To Hbv Core 18-27" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 340 no PDB 3PWJ . "Human Class I Mhc Hla-A2 In Complex With The Hud (G2l,I9v) Peptide Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 341 no PDB 3PWL . "Human Class I Mhc Hla-A2 In Complex With The Hud Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 342 no PDB 3PWN . "Human Class I Mhc Hla-A2 In Complex With The Hud (G2l) Peptide Variant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 343 no PDB 3PWP . "The Complex Between Tcr A6 And Human Class I Mhc Hla-A2 With The Bound Hud Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 344 no PDB 3QDA . "Crystal Structure Of W95l Beta-2 Microglobulin" . . . . . 100.00 100 100.00 100.00 3.61e-06 . . . . 10022 1 345 no PDB 3QDG . "The Complex Between Tcr Dmf5 And Human Class I Mhc Hla-A2 With The Bound Mart-1(26-35)(A27l) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 346 no PDB 3QDJ . "The Complex Between Tcr Dmf5 And Human Class I Mhc Hla-A2 With The Bound Mart-1(27-35) Nonameric Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 347 no PDB 3QDM . "The Complex Between Tcr Dmf4 And Human Class I Mhc Hla-A2 With The Bound Mart-1(26-35)(A27l) Decameric Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 348 no PDB 3QEQ . "The Complex Between Tcr Dmf4 And Human Class I Mhc Hla-A2 With The Bound Mart-1(27-35) Nonameric Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 349 no PDB 3QFD . "Human Class I Mhc Hla-A2 In Complex With Mart-1(27-35) Nonameric Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 350 no PDB 3QFJ . "The Complex Between Tcr A6 And Human Class I Mhc Hla-A2 With The Modified Tax (Y5f) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 351 no PDB 3QZW . "Plasticity Of Human Cd8 Binding To Peptide-hla-a*2402" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 352 no PDB 3REW . "Crystal Structure Of An Lmp2a-Derived Peptide Bound To Human Class I Mhc Hla-A2" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 353 no PDB 3RL1 . "Hiv Rt Derived Peptide Complexed To Hla-A0301" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 354 no PDB 3RL2 . "Hiv Nef Derived Peptide Nef73 Complexed To Hla-A0301" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 355 no PDB 3RWC . "Crystal Structure Of Rhesus Macaque Mhc Class I Molecule Mamu-B17-Iw9" . . . . . 95.45 99 100.00 100.00 1.69e-05 . . . . 10022 1 356 no PDB 3RWD . "Rhesus Macaque Mhc Class I Molecule Mamu-B17-Iw11" . . . . . 95.45 99 100.00 100.00 1.69e-05 . . . . 10022 1 357 no PDB 3RWE . "Rhesus Macaque Mhc Class I Molecule Mamu-B17-Fw9" . . . . . 95.45 99 100.00 100.00 1.69e-05 . . . . 10022 1 358 no PDB 3RWF . "Rhesus Macaque Mhc Class I Molecule Mamu-B17-Qw9" . . . . . 95.45 100 100.00 100.00 1.65e-05 . . . . 10022 1 359 no PDB 3RWG . "Rhesus Macaque Mhc Class I Molecule Mamu-B17-Mw9" . . . . . 95.45 100 100.00 100.00 1.65e-05 . . . . 10022 1 360 no PDB 3RWH . "Rhesus Macaque Mhc Class I Molecule Mamu-B17-Mf8" . . . . . 95.45 99 100.00 100.00 1.69e-05 . . . . 10022 1 361 no PDB 3RWI . "Rhesus Macaque Mhc Class I Molecule Mamu-B17-Gw10" . . . . . 95.45 99 100.00 100.00 1.69e-05 . . . . 10022 1 362 no PDB 3RWJ . "Rhesus Macaque Mhc Class I Molecule Mamu-B17-Hw8" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 363 no PDB 3S6C . "Structure Of Human Cd1e" . . . . . 100.00 392 100.00 100.00 2.41e-06 . . . . 10022 1 364 no PDB 3SDX . "Crystal Structure Of Human Autoreactive-Valpha24 Nkt Tcr In Complex With Cd1d-Beta-Galactosylceramide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 365 no PDB 3SJV . "Crystal Structure Of The Rl42 Tcr In Complex With Hla-B8-Flr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 366 no PDB 3SKM . "Crystal Structure Of The Hla-B8flrgrayvl, Mutant G8v Of The Flr Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 367 no PDB 3SKO . "Crystal Structure Of The Hla-B8-A66-Flr, Mutant A66 Of The Hla B8" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 368 no PDB 3SPV . "Crystal Structure Of A Peptide-Hla Complex" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 369 no PDB 3T8X . "Crystal Structure Of Human Cd1b In Complex With Synthetic Antigenic Diacylsulfoglycolipid Sgl12 And Endogenous Spacer" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 370 no PDB 3TID . "Crystal Structure Of The Lcmv Derived Peptide Gp34 In Complex With The Murine Mhc Class I H-2 Kb" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 371 no PDB 3TIE . "Crystal Structure Of The Vaccinia Derived Peptide A11r In Complex With The Murine Mhc Class I H-2 Kb" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 372 no PDB 3TLR . "Crystal Structure Of The Tetrameric Beta-2 Microglobulin Dimc20 Mutant" . . . . . 95.45 100 100.00 100.00 1.47e-05 . . . . 10022 1 373 no PDB 3TM6 . "Crystal Structure Of The Beta-2 Microglobulin Dimc50 Disulphide-linked Homodimer Mutant" . . . . . 100.00 100 100.00 100.00 4.46e-06 . . . . 10022 1 374 no PDB 3TO2 . "Structure Of Hla-A0201 Complexed With Peptide Md3-C9 Derived From A Clustering Region Of Restricted Cytotoxic T Lymphocyte Epit" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 375 no PDB 3TZV . "Crystal Structure Of An Inkt Tcr In Complex With Cd1d- Lysophosphatidylcholine" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 376 no PDB 3U0P . "Crystal Structure Of Human Cd1d-Lysophosphatidylcholine" . . . . . 100.00 102 100.00 100.00 3.86e-06 . . . . 10022 1 377 no PDB 3UPR . "Hla-B57:01 Complexed To Pep-V And Abacavir" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 378 no PDB 3UTQ . "Human Hla-A0201-Alwgpdpaaa" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 379 no PDB 3UTS . "1e6-A0201-Alwgpdpaaa Complex, Monoclinic" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 380 no PDB 3UTT . "1e6-A0201-Alwgpdpaaa Complex, Triclinic" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 381 no PDB 3V5D . "Hla-A2.1 Kvaelvhfl" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 382 no PDB 3V5H . "Hla-A2.1 Kvaeivhfl" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 383 no PDB 3V5K . "Hla2.1 Kvaelvwfl" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 384 no PDB 3VCL . "Crystal Structure Of Hla-B7 With The Hcmv Pp65 Peptide Rpherngftvl" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 385 no PDB 3VFM . "Crystal Structure Of Hla B3508 Lpep155a, Hla Mutant Ala155" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 386 no PDB 3VFN . "Crystal Structure Of Hla B3508lpep151a, Hla Mutant Ala151" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 387 no PDB 3VFO . "Crystal Structure Of Hla B3508 Lpep157a, Hla Mutant Ala157" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 388 no PDB 3VFP . "Crystal Structure Of Hla B3508 Lpep158g, Hla Mutant Gly158" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 389 no PDB 3VFR . "Crystal Structure Of Hla B3508lpep-P4ala, Peptide Mutant P4-Ala" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 390 no PDB 3VFS . "Crystal Structure Of Hla B3508lpep-P5ala , Peptide Mutant P5-Ala" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 391 no PDB 3VFT . "Crystal Structure Of Hla B3508lpep-P6ala, Peptide Mutant P6-Ala" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 392 no PDB 3VFU . "Crystal Structure Of Hla B3508 Lpep-P7ala, Peptide Mutant P7-Ala" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 393 no PDB 3VFV . "Crystal Structure Of Hla B3508 Lpep-P9ala, Peptide Mutant P9-Ala" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 394 no PDB 3VFW . "Crystal Structure Of Hla B3508 Lpep-P10ala, Peptide Mutant P10-Ala" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 395 no PDB 3VH8 . "Kir3dl1 In Complex With Hla-B5701" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 396 no PDB 3VRI . "Hla-B57:01-Rvaqlenvyi In Complex With Abacavir" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 397 no PDB 3VRJ . "Hla-B57:01-Lttkltntni In Complex With Abacavir" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 398 no PDB 3VWJ . "Ternary Crystal Structure Of The Human Nkt Tcr-cd1d-c20:2 Complex" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 399 no PDB 3VWK . "Ternary Crystal Structure Of The Human Nkt Tcr-cd1d-4'deoxy-alpha- Galactosylceramide Complex" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 400 no PDB 3VXM . "The Complex Between C1-28 Tcr And Hla-a24 Bound To Hiv-1 Nef134-10(2f) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 401 no PDB 3VXN . "Hla-a24 In Complex With Hiv-1 Nef134-10(wt)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 402 no PDB 3VXO . "Hla-a24 In Complex With Hiv-1 Nef134-10(2f)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 403 no PDB 3VXP . "Hla-a24 In Complex With Hiv-1 Nef134-10(6l)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 404 no PDB 3VXR . "The Complex Between H27-14 Tcr And Hla-a24 Bound To Hiv-1 Nef134- 10(wt) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 405 no PDB 3VXS . "The Complex Between H27-14 Tcr And Hla-a24 Bound To Hiv-1 Nef134- 10(6l) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 406 no PDB 3VXU . "The Complex Between T36-5 Tcr And Hla-a24 Bound To Hiv-1 Nef134-10(2f) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 407 no PDB 3W0W . "The Complex Between T36-5 Tcr And Hla-a24 Bound To Hiv-1 Nef134-10(2f) Peptide In Space Group P212121" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 408 no PDB 3W39 . "Crystal Structure Of Hla-b*5201 In Complexed With Hiv Immunodominant Epitope (taftipsi)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 409 no PDB 3WL9 . "Hla-a24 In Complex With Hiv-1 Nef126-10(8i10f)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 410 no PDB 3WLB . "Hla-a24 In Complex With Hiv-1 Nef126-10(8t10f)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 411 no PDB 3WUW . "Kir3dl1 In Complex With Hla-b*57:01.i80t" . . . . . 100.00 98 100.00 100.00 3.55e-06 . . . . 10022 1 412 no PDB 4E5X . "Crystal Structure Of A Complex Between The Human Adenovirus Type 2 E3- 19k Protein And Mhc Class I Molecule Hla-A2TAX" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 413 no PDB 4EN3 . "Crystal Structure Of A Human Valpha24(-) Nkt Tcr In Complex With Cd1d/alpha-galactosylceramide" . . . . . 100.00 100 100.00 100.00 3.84e-06 . . . . 10022 1 414 no PDB 4EUP . "The Complex Between Tcr Jkf6 And Human Class I Mhc Hla-a2 Presenting The Mart-1(27-35)(a27l) Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 415 no PDB 4F7M . "Crystal Structure Of Hla-A2402 Complexed With A Newly Identified Peptide From 2009 H1n1 Pa (649-658)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 416 no PDB 4F7P . "Crystal Structure Of Hla-a*2402 Complexed With A Newly Identified Peptide From 2009h1n1 Pb1 (496-505)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 417 no PDB 4F7T . "Crystal Structure Of Hla-A2402 Complexed With A Newly Identified Peptide From 2009 H1n1 Pb1 (498-505)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 418 no PDB 4FTV . "The Complex Between The High Affinity Version Of A6 Tcr (a6c134) And Human Class I Mhc Hla-a2 With The Bound Tax Nonameric Pept" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 419 no PDB 4FXL . "Crystal Structure Of The D76n Beta-2 Microglobulin Mutant" . . . . . 100.00 100 100.00 100.00 3.43e-06 . . . . 10022 1 420 no PDB 4G8G . "Crystal Structure Of C12c Tcr-ha B2705-kk10" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 421 no PDB 4G8I . "Crystal Structure Of Hla B2705-kk10-l6m" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 422 no PDB 4G9D . "Crystal Structure Of Hla B2705-kk10" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 423 no PDB 4G9F . "Crystal Structure Of C12c Tcr-hlab2705-kk10-l6m" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 424 no PDB 4GKN . "A2-Mhc Complex Carrying Fatgigiitv" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 425 no PDB 4GKS . "A2-Mhc Complex Carrying Fltgigiitv" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 426 no PDB 4GUP . "Structure Of Mhc-Class I Related Molecule Mr1" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 427 no PDB 4HKJ . "Structure Of Cowpox Cpxv203 In Complex With Mhci (H-2kb)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 428 no PDB 4HWZ . "Structure Of Hla-a68 Complexed With An Hiv Derived Peptide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 429 no PDB 4HX1 . "Structure Of Hla-a68 Complexed With A Tumor Antigen Derived Peptide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 430 no PDB 4I48 . "Structure Of Hla-a68 Complexed With An Hiv Env Derived Peptide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 431 no PDB 4I4W . "Peptide Length Determines The Outcome Of T Cell Receptor/peptide-mhci Engagement" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 432 no PDB 4JFD . "Preservation Of Peptide Specificity During Tcr-mhc Contact Dominated Affinity Enhancement Of A Melanoma-specific Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 433 no PDB 4JFE . "Preservation Of Peptide Specificity During Tcr-mhc Contact Dominated Affinity Enhancement Of A Melanoma-specific Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 434 no PDB 4JFF . "Preservation Of Peptide Specificity During Tcr-mhc Contact Dominated Affinity Enhancement Of A Melanoma-specific Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 435 no PDB 4JFO . "A2 Hla Complex With E1a Heteroclitic Variant Of Melanoma Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 436 no PDB 4JFP . "A2 Hla Complex With G4a Heteroclitic Variant Of Melanoma Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 437 no PDB 4JFQ . "A2 Hla Complex With L8a Heteroclitic Variant Of Melanoma Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 438 no PDB 4JQV . "Hla-b*18:01 In Complex With Epstein-barr Virus Bzlf1-derived Peptide (residues 173-180)" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 439 no PDB 4JQX . "Hla-b*44:03 In Complex With Epstein-barr Virus Bzlf1-derived Peptide (residues 169-180)" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 440 no PDB 4JRX . "Crystal Structure Of Ca5 Tcr-hla B*3505-lpep Complex" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 441 no PDB 4JRY . "Crystal Structure Of Sb47 Tcr-hla B*3505-lpep Complex" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 442 no PDB 4K71 . "Crystal Structure Of A High Affinity Human Serum Albumin Variant Bound To The Neonatal Fc Receptor" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 443 no PDB 4K7F . "Newly Identified Epitope V60 From Hbv Core Protein Complexed With Hla- A*0201" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 444 no PDB 4L29 . "Structure Of Wtmhc Class I With Ny-eso1 Double Mutant" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 445 no PDB 4L3C . "Structure Of Hla-a2 In Complex With D76n B2m Mutant And Ny-eso1 Double Mutant" . . . . . 100.00 100 100.00 100.00 3.43e-06 . . . . 10022 1 446 no PDB 4L3E . "The Complex Between High Affinity Tcr Dmf5(alpha-d26y,beta-l98w) And Human Class I Mhc Hla-a2 With The Bound Mart-1(26-35)(a27l" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 447 no PDB 4L4T . "Structure Of Human Mait Tcr In Complex With Human Mr1-6-fp" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 448 no PDB 4L4V . "Structure Of Human Mait Tcr In Complex With Human Mr1-rl-6-me-7-oh" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 449 no PDB 4LCW . "The Structure Of Human Mait Tcr In Complex With Mr1-k43a-rl-6-me-7oh" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 450 no PDB 4LCY . "Crystal Structure Of Hla-b46 At 1.6 Angstrom Resolution" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 451 no PDB 4LHU . "Crystal Structure Of 9c2 Tcr Bound To Cd1d" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 452 no PDB 4LNR . "The Structure Of Hla-b*35:01 In Complex With The Peptide (rpqvplrpmty)" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 453 no PDB 4M8V . "Crystal Structure Of Human Double Mutant Beta2-microglobulin Q8h-l65t" . . . . . 100.00 100 100.00 100.00 3.61e-06 . . . . 10022 1 454 no PDB 4MJ5 . "Hla-a11 Complexed With A Pepitde" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 455 no PDB 4MJ6 . "Hla-a11 Complexed With A Mutated Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 456 no PDB 4MJI . "T Cell Response To A Hiv Reverse Transcriptase Epitope Presented By The Protective Allele Hla-b*51:01" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 457 no PDB 4MNQ . "Tcr-peptide Specificity Overrides Affinity Enhancing Tcr-mhc Interactions" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 458 no PDB 4N0F . "Human Fcrn Complexed With Human Serum Albumin" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 459 no PDB 4N0U . "Ternary Complex Between Neonatal Fc Receptor, Serum Albumin And Fc" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 460 no PDB 4N8V . "Crystal Structure Of Killer Cell Immunoglobulin-like Receptor Kir2ds2 In Complex With Hla-a" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 461 no PDB 4NNX . "Crystal Structure Of Pkd2 Phosphopeptide Bound To Hla-a2" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 462 no PDB 4NNY . "Crystal Structure Of Non-phosphorylated Form Of Pkd2 Phosphopeptide Bound To Hla-a2" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 463 no PDB 4NO0 . "Crystal Structure Of Non-phosphorylated Form Of Rqa_v Phosphopeptide Bound To Hla-a2 In Complex With Lilrb1" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 464 no PDB 4NO2 . "Crystal Structure Of Rqa_v Phosphopeptide Bound To Hla-a2" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 465 no PDB 4NQC . "Crystal Structure Of Tcr-mr1 Ternary Complex And Covalently Bound 5- (2-oxopropylideneamino)-6-d-ribitylaminouracil" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 466 no PDB 4NQD . "Crystal Structure Of Tcr-mr1 Ternary Complex And Non-covalently Bound 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 467 no PDB 4NQE . "Crystal Structure Of Tcr-mr1 Ternary Complex Bound To 5-(2- Oxoethylideneamino)-6-d-ribitylaminouracil" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 468 no PDB 4NQV . "Crystal Structure Of Hla A*0101 In Complex With Np44, An 9-mer Influenza Epitope" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 469 no PDB 4NQX . "Crystal Structure Of Hla A*0101 In Complex With Np44-s7n, An 9-mer Influenza Epitope" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 470 no PDB 4NT6 . "Hla-c*0801 Crystal Structure" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 471 no PDB 4O2C . "An Nt-acetylated Peptide Complexed With Hla-b*3901" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 472 no PDB 4O2E . "A Peptide Complexed With Hla-b*3901" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 473 no PDB 4O2F . "A Peptide Complexed With Hla-b*3901" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 474 no PDB 4ONO . "Cd1c In Complex With Pm (phosphomycoketide)" . . . . . 100.00 395 100.00 100.00 2.51e-06 . . . . 10022 1 475 no PDB 4PJ5 . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait Trbv6-1 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 476 no PDB 4PJ7 . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait Trbv6-4 Tcr" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 477 no PDB 4PJ8 . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait Trbv20 Tcr" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 478 no PDB 4PJ9 . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait Traj20 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 479 no PDB 4PJA . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait B-b10 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 480 no PDB 4PJB . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait B-f3-c1 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 481 no PDB 4PJC . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait C-a11 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 482 no PDB 4PJD . "Structure Of Human Mr1-5-op-ru In Complex With Human Mait C-c10 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 483 no PDB 4PJE . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait B-b10 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 484 no PDB 4PJF . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait B-c10 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 485 no PDB 4PJG . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait B-f3-c1 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 486 no PDB 4PJH . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait B-g8 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 487 no PDB 4PJI . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait C-c10 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 488 no PDB 4PJX . "Structure Of Human Mr1-ac-6-fp In Complex With Human Mait C-a11 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 489 no PDB 4PR5 . "Crystal Structure Of A Hla-b*35:01-hpvg-d5" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 490 no PDB 4PRA . "Crystal Structure Of A Hla-b*35:01-hpvg-q5" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 491 no PDB 4PRB . "Crystal Structure Of A Hla-b*35:08-hpvg-a4" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 492 no PDB 4PRD . "Crystal Structure Of A Hla-b*35:08-hpvg-d5" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 493 no PDB 4PRE . "Crystal Structure Of A Hla-b*35:08-hpvg-q5" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 494 no PDB 4PRH . "Crystal Structure Of Tk3 Tcr-hla-b*35:08-hpvg-d5 Complex" . . . . . 100.00 100 100.00 100.00 3.47e-06 . . . . 10022 1 495 no PDB 4PRI . "Crystal Structure Of Tk3 Tcr-hla-b*35:08-hpvg Complex" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 496 no PDB 4PRN . "Crystal Structure Of A Hla-b*35:01-hpvg-a4" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 497 no PDB 4PRP . "Crystal Structure Of Tk3 Tcr-hla-b*35:01-hpvg-q5 Complex" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 498 no PDB 4QOK . "Structural Basis For Ineffective T-cell Responses To Mhc Anchor Residue Improved Heteroclitic Peptides" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 499 no PDB 4QRP . "Crystal Structure Of Hla B*0801 In Complex With Hskkkcdel And Dd31 Tcr" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 500 no PDB 4QRQ . "Crystal Structure Of Hla B*0801 In Complex With Hskkkcdel" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 501 no PDB 4QRR . "Crystal Structure Of Hla B*3501-ips In Complex With A Delta-beta Tcr, Clone 12 Tcr" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 502 no PDB 4QRS . "Crystal Structure Of Hla B*0801 In Complex With Elk_iym, Elkrkmiym" . . . . . 100.00 100 100.00 100.00 3.76e-06 . . . . 10022 1 503 no PDB 4QRT . "Crystal Structure Of Hla B*0801 In Complex With Eln_yym, Elnrkmiym" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 504 no PDB 4QRU . "Crystal Structure Of Hla B*0801 In Complex With Elr_mym, Elrrkmmym" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 505 no PDB 4U1H . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 506 no PDB 4U1I . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 507 no PDB 4U1J . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 508 no PDB 4U1K . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 509 no PDB 4U1L . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 510 no PDB 4U1M . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 511 no PDB 4U1N . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 512 no PDB 4U1S . "Hla Class I Micropolymorphisms Determine Peptide-hla Landscape And Dictate Differential Hiv-1 Escape Through Identical Epitopes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 513 no PDB 4U6X . "Crystal Structure Of Hla-a*0201 In Complex With Alqda, A 15 Mer Self- Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 514 no PDB 4U6Y . "Crystal Structure Of Hla-a*0201 In Complex With Flndk, A 15 Mer Self- Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 515 no PDB 4UQ2 . "Crystal Structure Of Hla-a1101 In Complex With An Azobenzene-containing Peptide" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 516 no PDB 4UQ3 . "Crystal Structure Of Hla-a0201 In Complex With An Azobenzene-containing Peptide" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 517 no PDB 4WDI . "Weak Tcr Binding To An Unstable Insulin Epitope Drives Type 1 Diabetes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 518 no PDB 4WJ5 . "Structure Of Hla-a2 In Complex With An Altered Peptide Ligands Based On Mart-1 Variant Epitope" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 519 no PDB 4WO4 . "The Molecular Bases Of Delta/alpha Beta T Cell-mediated Antigen Recognition." . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 520 no PDB 4WU5 . "Hla-a24 In Complex With Hiv-1 Nef134-8(wt)" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 521 no PDB 4WU7 . "Hla-a24 In Complex With Hiv-1 Nef134-8(2f)" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 522 no PDB 4X6C . "Cd1a Ternary Complex With Lysophosphatidylcholine And Bk6 Tcr" . . . . . 100.00 105 100.00 100.00 3.91e-06 . . . . 10022 1 523 no PDB 4X6D . "Cd1a Ternary Complex With Endogenous Lipids And Bk6 Tcr" . . . . . 100.00 99 100.00 100.00 3.65e-06 . . . . 10022 1 524 no PDB 4X6E . "Cd1a Binary Complex With Lysophosphatidylcholine" . . . . . 100.00 105 100.00 100.00 3.91e-06 . . . . 10022 1 525 no PDB 4X6F . "Cd1a Binary Complex With Sphingomyelin" . . . . . 100.00 105 100.00 100.00 3.91e-06 . . . . 10022 1 526 no PDB 4XXC . "Hla-b*1801 In Complex With A Self-peptide, Deleikay" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 527 no PDB 4Z76 . "Weak Tcr Binding To An Unstable Insulin Epitope Drives Type 1 Diabetes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 528 no PDB 4Z77 . "Weak Tcr Binding To An Unstable Insulin Epitope Drives Type 1 Diabetes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 529 no PDB 4Z78 . "Weak Tcr Binding To An Unstable Insulin Epitope Drives Type 1 Diabetes" . . . . . 100.00 100 100.00 100.00 3.50e-06 . . . . 10022 1 530 no PDB 5BXF . "Apo Fcrn Structure At Ph 4.5" . . . . . 100.00 119 100.00 100.00 2.97e-06 . . . . 10022 1 531 no DBJ BAA35182 . "beta 2-microglobulin [Homo sapiens]" . . . . . 100.00 119 100.00 100.00 2.97e-06 . . . . 10022 1 532 no DBJ BAE01010 . "unnamed protein product [Macaca fascicularis]" . . . . . 95.45 119 100.00 100.00 1.37e-05 . . . . 10022 1 533 no DBJ BAE87778 . "unnamed protein product [Macaca fascicularis]" . . . . . 95.45 119 100.00 100.00 1.39e-05 . . . . 10022 1 534 no DBJ BAG38125 . "unnamed protein product [Homo sapiens]" . . . . . 100.00 119 100.00 100.00 2.97e-06 . . . . 10022 1 535 no DBJ BAG64583 . "unnamed protein product [Homo sapiens]" . . . . . 100.00 122 100.00 100.00 2.65e-06 . . . . 10022 1 536 no EMBL CAA23830 . "beta-2 microglobulin [Homo sapiens]" . . . . . 100.00 110 100.00 100.00 3.55e-06 . . . . 10022 1 537 no EMBL CAG33347 . "B2M [Homo sapiens]" . . . . . 100.00 119 100.00 100.00 2.97e-06 . . . . 10022 1 538 no EMBL CAH92078 . "hypothetical protein [Pongo abelii]" . . . . . 100.00 119 100.00 100.00 2.97e-06 . . . . 10022 1 539 no GB AAA87972 . "beta-2-microglobulin [Pan troglodytes]" . . . . . 100.00 119 100.00 100.00 2.97e-06 . . . . 10022 1 540 no GB AAA88008 . "beta-2-microglobulin [Gorilla gorilla]" . . . . . 100.00 119 100.00 100.00 2.97e-06 . . . . 10022 1 541 no GB AAA88837 . "beta-2-microglobulin [Pongo pygmaeus]" . . . . . 100.00 119 100.00 100.00 2.71e-06 . . . . 10022 1 542 no GB AAB25312 . "beta 2-microglobulin [Homo sapiens]" . . . . . 100.00 101 100.00 100.00 2.11e-06 . . . . 10022 1 543 no GB AAB31321 . "beta 2-microglobulin, partial [Saguinus oedipus]" . . . . . 95.45 99 100.00 100.00 1.61e-05 . . . . 10022 1 544 no REF NP_001009066 . "beta-2-microglobulin precursor [Pan troglodytes]" . . . . . 100.00 119 100.00 100.00 2.97e-06 . . . . 10022 1 545 no REF NP_001040602 . "beta-2-microglobulin precursor [Macaca mulatta]" . . . . . 95.45 119 100.00 100.00 1.28e-05 . . . . 10022 1 546 no REF NP_001127503 . "beta-2-microglobulin precursor [Pongo abelii]" . . . . . 100.00 119 100.00 100.00 2.97e-06 . . . . 10022 1 547 no REF NP_001167006 . "beta-2-microglobulin precursor [Papio anubis]" . . . . . 95.45 119 100.00 100.00 1.28e-05 . . . . 10022 1 548 no REF NP_001271618 . "beta-2-microglobulin precursor [Macaca fascicularis]" . . . . . 95.45 119 100.00 100.00 1.39e-05 . . . . 10022 1 549 no SP O77517 . "RecName: Full=Beta-2-microglobulin; Flags: Precursor" . . . . . 95.45 119 100.00 100.00 1.82e-05 . . . . 10022 1 550 no SP O77518 . "RecName: Full=Beta-2-microglobulin; Flags: Precursor" . . . . . 95.45 119 100.00 100.00 1.48e-05 . . . . 10022 1 551 no SP O77519 . "RecName: Full=Beta-2-microglobulin; Flags: Precursor" . . . . . 95.45 119 100.00 100.00 1.62e-05 . . . . 10022 1 552 no SP O77520 . "RecName: Full=Beta-2-microglobulin; Flags: Precursor" . . . . . 95.45 119 100.00 100.00 1.21e-05 . . . . 10022 1 553 no SP O77521 . "RecName: Full=Beta-2-microglobulin; Flags: Precursor" . . . . . 95.45 119 100.00 100.00 1.48e-05 . . . . 10022 1 stop_ loop_ _Entity_common_name.Name _Entity_common_name.Type _Entity_common_name.Entry_ID _Entity_common_name.Entity_ID 'amyloid protofibrils of beta2-microglobulin fragment' common 10022 1 stop_ loop_ _Entity_comp_index.ID _Entity_comp_index.Auth_seq_ID _Entity_comp_index.Comp_ID _Entity_comp_index.Comp_label _Entity_comp_index.Entry_ID _Entity_comp_index.Entity_ID 1 20 SER . 10022 1 2 21 ASN . 10022 1 3 22 PHE . 10022 1 4 23 LEU . 10022 1 5 24 ASN . 10022 1 6 25 CYS . 10022 1 7 26 TYR . 10022 1 8 27 VAL . 10022 1 9 28 SER . 10022 1 10 29 GLY . 10022 1 11 30 PHE . 10022 1 12 31 HIS . 10022 1 13 32 PRO . 10022 1 14 33 SER . 10022 1 15 34 ASP . 10022 1 16 35 ILE . 10022 1 17 36 GLU . 10022 1 18 37 VAL . 10022 1 19 38 ASP . 10022 1 20 39 LEU . 10022 1 21 40 LEU . 10022 1 22 41 LYS . 10022 1 stop_ loop_ _Entity_poly_seq.Hetero _Entity_poly_seq.Mon_ID _Entity_poly_seq.Num _Entity_poly_seq.Comp_index_ID _Entity_poly_seq.Entry_ID _Entity_poly_seq.Entity_ID . SER 1 1 10022 1 . ASN 2 2 10022 1 . PHE 3 3 10022 1 . LEU 4 4 10022 1 . ASN 5 5 10022 1 . CYS 6 6 10022 1 . TYR 7 7 10022 1 . VAL 8 8 10022 1 . SER 9 9 10022 1 . GLY 10 10 10022 1 . PHE 11 11 10022 1 . HIS 12 12 10022 1 . PRO 13 13 10022 1 . SER 14 14 10022 1 . ASP 15 15 10022 1 . ILE 16 16 10022 1 . GLU 17 17 10022 1 . VAL 18 18 10022 1 . ASP 19 19 10022 1 . LEU 20 20 10022 1 . LEU 21 21 10022 1 . LYS 22 22 10022 1 stop_ save_ #################### # Natural source # #################### save_natural_source _Entity_natural_src_list.Sf_category natural_source _Entity_natural_src_list.Sf_framecode natural_source _Entity_natural_src_list.Entry_ID 10022 _Entity_natural_src_list.ID 1 loop_ _Entity_natural_src.ID _Entity_natural_src.Entity_ID _Entity_natural_src.Entity_label _Entity_natural_src.Entity_chimera_segment_ID _Entity_natural_src.NCBI_taxonomy_ID _Entity_natural_src.Type _Entity_natural_src.Common _Entity_natural_src.Organism_name_scientific _Entity_natural_src.Organism_name_common _Entity_natural_src.Organism_acronym _Entity_natural_src.ICTVdb_decimal_code _Entity_natural_src.Superkingdom _Entity_natural_src.Kingdom _Entity_natural_src.Genus _Entity_natural_src.Species _Entity_natural_src.Strain _Entity_natural_src.Variant _Entity_natural_src.Subvariant _Entity_natural_src.Organ _Entity_natural_src.Tissue _Entity_natural_src.Tissue_fraction _Entity_natural_src.Cell_line _Entity_natural_src.Cell_type _Entity_natural_src.ATCC_number _Entity_natural_src.Organelle _Entity_natural_src.Cellular_location _Entity_natural_src.Fragment _Entity_natural_src.Fraction _Entity_natural_src.Secretion _Entity_natural_src.Plasmid _Entity_natural_src.Plasmid_details _Entity_natural_src.Gene_mnemonic _Entity_natural_src.Dev_stage _Entity_natural_src.Details _Entity_natural_src.Citation_ID _Entity_natural_src.Citation_label _Entity_natural_src.Entry_ID _Entity_natural_src.Entity_natural_src_list_ID 1 1 $K3_peptide_of_beta2-m . 9606 . no . human . . Eukaryota Metazoa Homo sapiens . . . . . . . . . . . . no . . . . . . . . 10022 1 stop_ save_ ######################### # Experimental source # ######################### save_experimental_source _Entity_experimental_src_list.Sf_category experimental_source _Entity_experimental_src_list.Sf_framecode experimental_source _Entity_experimental_src_list.Entry_ID 10022 _Entity_experimental_src_list.ID 1 loop_ _Entity_experimental_src.ID _Entity_experimental_src.Entity_ID _Entity_experimental_src.Entity_label _Entity_experimental_src.Entity_chimera_segment_ID _Entity_experimental_src.Production_method _Entity_experimental_src.Host_org_scientific_name _Entity_experimental_src.Host_org_name_common _Entity_experimental_src.Host_org_details _Entity_experimental_src.Host_org_NCBI_taxonomy_ID _Entity_experimental_src.Host_org_genus _Entity_experimental_src.Host_org_species _Entity_experimental_src.Host_org_strain _Entity_experimental_src.Host_org_variant _Entity_experimental_src.Host_org_subvariant _Entity_experimental_src.Host_org_organ _Entity_experimental_src.Host_org_tissue _Entity_experimental_src.Host_org_tissue_fraction _Entity_experimental_src.Host_org_cell_line _Entity_experimental_src.Host_org_cell_type _Entity_experimental_src.Host_org_cellular_location _Entity_experimental_src.Host_org_organelle _Entity_experimental_src.Host_org_gene _Entity_experimental_src.Host_org_culture_collection _Entity_experimental_src.Host_org_ATCC_number _Entity_experimental_src.Vector_type _Entity_experimental_src.PDBview_host_org_vector_name _Entity_experimental_src.PDBview_plasmid_name _Entity_experimental_src.Vector_name _Entity_experimental_src.Vector_details _Entity_experimental_src.Vendor_name _Entity_experimental_src.Host_org_dev_stage _Entity_experimental_src.Details _Entity_experimental_src.Citation_ID _Entity_experimental_src.Citation_label _Entity_experimental_src.Entry_ID _Entity_experimental_src.Entity_experimental_src_list_ID 1 1 $K3_peptide_of_beta2-m . 'recombinant technology' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10022 1 stop_ save_ ##################################### # Sample contents and methodology # ##################################### ######################## # Sample description # ######################## save_sample_1 _Sample.Sf_category sample _Sample.Sf_framecode sample_1 _Sample.Entry_ID 10022 _Sample.ID 1 _Sample.Type fiber _Sample.Sub_type . _Sample.Details . _Sample.Aggregate_sample_number . _Sample.Solvent_system . _Sample.Preparation_date . _Sample.Preparation_expiration_date . _Sample.Polycrystallization_protocol . _Sample.Single_crystal_protocol . _Sample.Crystal_grow_apparatus . _Sample.Crystal_grow_atmosphere . _Sample.Crystal_grow_details . _Sample.Crystal_grow_method . _Sample.Crystal_grow_method_cit_ID . _Sample.Crystal_grow_pH . _Sample.Crystal_grow_pH_range . _Sample.Crystal_grow_pressure . _Sample.Crystal_grow_pressure_esd . _Sample.Crystal_grow_seeding . _Sample.Crystal_grow_seeding_cit_ID . _Sample.Crystal_grow_temp . _Sample.Crystal_grow_temp_details . _Sample.Crystal_grow_temp_esd . _Sample.Crystal_grow_time . _Sample.Oriented_sample_prep_protocol . _Sample.Lyophilization_cryo_protectant . _Sample.Storage_protocol . loop_ _Sample_component.ID _Sample_component.Mol_common_name _Sample_component.Isotopic_labeling _Sample_component.Assembly_ID _Sample_component.Assembly_label _Sample_component.Entity_ID _Sample_component.Entity_label _Sample_component.Product_ID _Sample_component.Type _Sample_component.Concentration_val _Sample_component.Concentration_val_min _Sample_component.Concentration_val_max _Sample_component.Concentration_val_units _Sample_component.Concentration_val_err _Sample_component.Vendor _Sample_component.Vendor_product_name _Sample_component.Vendor_product_code _Sample_component.Entry_ID _Sample_component.Sample_ID 1 'amyloid protofibrils of beta2-microglobulin fragment' . 1 $assembly 1 $K3_peptide_of_beta2-m . protein 10 . . mg 2 . . . 10022 1 stop_ save_ ####################### # Sample conditions # ####################### save_condition_1 _Sample_condition_list.Sf_category sample_conditions _Sample_condition_list.Sf_framecode condition_1 _Sample_condition_list.Entry_ID 10022 _Sample_condition_list.ID 1 _Sample_condition_list.Details . loop_ _Sample_condition_variable.Type _Sample_condition_variable.Val _Sample_condition_variable.Val_err _Sample_condition_variable.Val_units _Sample_condition_variable.Entry_ID _Sample_condition_variable.Sample_condition_list_ID temperature 298 1 K 10022 1 stop_ save_ ######################### # Experimental detail # ######################### ################################## # NMR Spectrometer definitions # ################################## save_spectrometer_1 _NMR_spectrometer.Sf_category NMR_spectrometer _NMR_spectrometer.Sf_framecode spectrometer_1 _NMR_spectrometer.Entry_ID 10022 _NMR_spectrometer.ID 1 _NMR_spectrometer.Details . _NMR_spectrometer.Manufacturer Varian _NMR_spectrometer.Model Infinity-500 _NMR_spectrometer.Serial_number . _NMR_spectrometer.Field_strength 500 save_ save_spectrometer_2 _NMR_spectrometer.Sf_category NMR_spectrometer _NMR_spectrometer.Sf_framecode spectrometer_2 _NMR_spectrometer.Entry_ID 10022 _NMR_spectrometer.ID 2 _NMR_spectrometer.Details . _NMR_spectrometer.Manufacturer Varian _NMR_spectrometer.Model Infinity-600 _NMR_spectrometer.Serial_number . _NMR_spectrometer.Field_strength 600 save_ save_spectrometer_3 _NMR_spectrometer.Sf_category NMR_spectrometer _NMR_spectrometer.Sf_framecode spectrometer_3 _NMR_spectrometer.Entry_ID 10022 _NMR_spectrometer.ID 3 _NMR_spectrometer.Details . _NMR_spectrometer.Manufacturer Varian _NMR_spectrometer.Model Infinity-700 _NMR_spectrometer.Serial_number . _NMR_spectrometer.Field_strength 700 save_ ############################# # NMR applied experiments # ############################# save_NMR_experiment_list _Experiment_list.Sf_category experiment_list _Experiment_list.Sf_framecode NMR_experiment_list _Experiment_list.Entry_ID 10022 _Experiment_list.ID 1 _Experiment_list.Details . loop_ _Experiment.ID _Experiment.Name _Experiment.Raw_data_flag _Experiment.NMR_spec_expt_ID _Experiment.NMR_spec_expt_label _Experiment.MS_expt_ID _Experiment.MS_expt_label _Experiment.SAXS_expt_ID _Experiment.SAXS_expt_label _Experiment.FRET_expt_ID _Experiment.FRET_expt_label _Experiment.EMR_expt_ID _Experiment.EMR_expt_label _Experiment.Sample_ID _Experiment.Sample_label _Experiment.Sample_state _Experiment.Sample_volume _Experiment.Sample_volume_units _Experiment.Sample_condition_list_ID _Experiment.Sample_condition_list_label _Experiment.Sample_spinning_rate _Experiment.Sample_angle _Experiment.NMR_tube_type _Experiment.NMR_spectrometer_ID _Experiment.NMR_spectrometer_label _Experiment.NMR_spectrometer_probe_ID _Experiment.NMR_spectrometer_probe_label _Experiment.NMR_spectral_processing_ID _Experiment.NMR_spectral_processing_label _Experiment.Mass_spectrometer_ID _Experiment.Mass_spectrometer_label _Experiment.Xray_instrument_ID _Experiment.Xray_instrument_label _Experiment.Fluorescence_instrument_ID _Experiment.Fluorescence_instrument_label _Experiment.EMR_instrument_ID _Experiment.EMR_instrument_label _Experiment.Chromatographic_system_ID _Experiment.Chromatographic_system_label _Experiment.Chromatographic_column_ID _Experiment.Chromatographic_column_label _Experiment.Entry_ID _Experiment.Experiment_list_ID 1 2D-3D-13C-13C-RFDR no . . . . . . . . . . 1 $sample_1 . . . 1 $condition_1 . . . 3 $spectrometer_3 . . . . . . . . . . . . . . . . 10022 1 2 2D-3D-13C-13C-DARR no . . . . . . . . . . 1 $sample_1 . . . 1 $condition_1 . . . 3 $spectrometer_3 . . . . . . . . . . . . . . . . 10022 1 3 2D-13C-13C-SPCz5 no . . . . . . . . . . 1 $sample_1 . . . 1 $condition_1 . . . 3 $spectrometer_3 . . . . . . . . . . . . . . . . 10022 1 4 2D-13C-13C-INADEQUATE no . . . . . . . . . . 1 $sample_1 . . . 1 $condition_1 . . . 3 $spectrometer_3 . . . . . . . . . . . . . . . . 10022 1 5 2D-3D-15N-13C-RFDR no . . . . . . . . . . 1 $sample_1 . . . 1 $condition_1 . . . 1 $spectrometer_1 . . . . . . . . . . . . . . . . 10022 1 6 3D-15N-13C-SPECIFIC_CP no . . . . . . . . . . 1 $sample_1 . . . 1 $condition_1 . . . 1 $spectrometer_1 . . . . . . . . . . . . . . . . 10022 1 7 2D-13C-HH-13C-SPIN_DIFF no . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10022 1 stop_ save_ save_2D-3D-13C-13C-RFDR _NMR_spec_expt.Sf_category NMR_spectrometer_expt _NMR_spec_expt.Sf_framecode 2D-3D-13C-13C-RFDR _NMR_spec_expt.Entry_ID 10022 _NMR_spec_expt.ID 1 _NMR_spec_expt.Name 2D-3D-13C-13C-RFDR _NMR_spec_expt.Type . _NMR_spec_expt.Sample_volume . _NMR_spec_expt.Sample_volume_units . _NMR_spec_expt.NMR_tube_type . _NMR_spec_expt.Sample_spinning_rate . _NMR_spec_expt.Sample_angle . _NMR_spec_expt.NMR_spectrometer_ID 3 _NMR_spec_expt.NMR_spectrometer_label $spectrometer_3 _NMR_spec_expt.NMR_spectrometer_probe_ID . _NMR_spec_expt.NMR_spectrometer_probe_label . _NMR_spec_expt.Carrier_freq_switch_time . _NMR_spec_expt.Software_ID . _NMR_spec_expt.Software_label . _NMR_spec_expt.Method_ID . _NMR_spec_expt.Method_label . _NMR_spec_expt.Pulse_seq_accession_BMRB_code . _NMR_spec_expt.Details . save_ save_2D-3D-13C-13C-DARR _NMR_spec_expt.Sf_category NMR_spectrometer_expt _NMR_spec_expt.Sf_framecode 2D-3D-13C-13C-DARR _NMR_spec_expt.Entry_ID 10022 _NMR_spec_expt.ID 2 _NMR_spec_expt.Name 2D-3D-13C-13C-DARR _NMR_spec_expt.Type . _NMR_spec_expt.Sample_volume . _NMR_spec_expt.Sample_volume_units . _NMR_spec_expt.NMR_tube_type . _NMR_spec_expt.Sample_spinning_rate . _NMR_spec_expt.Sample_angle . _NMR_spec_expt.NMR_spectrometer_ID 3 _NMR_spec_expt.NMR_spectrometer_label $spectrometer_3 _NMR_spec_expt.NMR_spectrometer_probe_ID . _NMR_spec_expt.NMR_spectrometer_probe_label . _NMR_spec_expt.Carrier_freq_switch_time . _NMR_spec_expt.Software_ID . _NMR_spec_expt.Software_label . _NMR_spec_expt.Method_ID . _NMR_spec_expt.Method_label . _NMR_spec_expt.Pulse_seq_accession_BMRB_code . _NMR_spec_expt.Details . save_ save_2D-13C-13C-SPCz5 _NMR_spec_expt.Sf_category NMR_spectrometer_expt _NMR_spec_expt.Sf_framecode 2D-13C-13C-SPCz5 _NMR_spec_expt.Entry_ID 10022 _NMR_spec_expt.ID 3 _NMR_spec_expt.Name 2D-13C-13C-SPCz5 _NMR_spec_expt.Type . _NMR_spec_expt.Sample_volume . _NMR_spec_expt.Sample_volume_units . _NMR_spec_expt.NMR_tube_type . _NMR_spec_expt.Sample_spinning_rate . _NMR_spec_expt.Sample_angle . _NMR_spec_expt.NMR_spectrometer_ID 3 _NMR_spec_expt.NMR_spectrometer_label $spectrometer_3 _NMR_spec_expt.NMR_spectrometer_probe_ID . _NMR_spec_expt.NMR_spectrometer_probe_label . _NMR_spec_expt.Carrier_freq_switch_time . _NMR_spec_expt.Software_ID . _NMR_spec_expt.Software_label . _NMR_spec_expt.Method_ID . _NMR_spec_expt.Method_label . _NMR_spec_expt.Pulse_seq_accession_BMRB_code . _NMR_spec_expt.Details . save_ save_2D-13C-13C-INADEQUATE _NMR_spec_expt.Sf_category NMR_spectrometer_expt _NMR_spec_expt.Sf_framecode 2D-13C-13C-INADEQUATE _NMR_spec_expt.Entry_ID 10022 _NMR_spec_expt.ID 4 _NMR_spec_expt.Name 2D-13C-13C-INADEQUATE _NMR_spec_expt.Type . _NMR_spec_expt.Sample_volume . _NMR_spec_expt.Sample_volume_units . _NMR_spec_expt.NMR_tube_type . _NMR_spec_expt.Sample_spinning_rate . _NMR_spec_expt.Sample_angle . _NMR_spec_expt.NMR_spectrometer_ID 3 _NMR_spec_expt.NMR_spectrometer_label $spectrometer_3 _NMR_spec_expt.NMR_spectrometer_probe_ID . _NMR_spec_expt.NMR_spectrometer_probe_label . _NMR_spec_expt.Carrier_freq_switch_time . _NMR_spec_expt.Software_ID . _NMR_spec_expt.Software_label . _NMR_spec_expt.Method_ID . _NMR_spec_expt.Method_label . _NMR_spec_expt.Pulse_seq_accession_BMRB_code . _NMR_spec_expt.Details . save_ save_2D-3D-15N-13C-RFDR _NMR_spec_expt.Sf_category NMR_spectrometer_expt _NMR_spec_expt.Sf_framecode 2D-3D-15N-13C-RFDR _NMR_spec_expt.Entry_ID 10022 _NMR_spec_expt.ID 5 _NMR_spec_expt.Name 2D-3D-15N-13C-RFDR _NMR_spec_expt.Type . _NMR_spec_expt.Sample_volume . _NMR_spec_expt.Sample_volume_units . _NMR_spec_expt.NMR_tube_type . _NMR_spec_expt.Sample_spinning_rate . _NMR_spec_expt.Sample_angle . _NMR_spec_expt.NMR_spectrometer_ID 1 _NMR_spec_expt.NMR_spectrometer_label $spectrometer_1 _NMR_spec_expt.NMR_spectrometer_probe_ID . _NMR_spec_expt.NMR_spectrometer_probe_label . _NMR_spec_expt.Carrier_freq_switch_time . _NMR_spec_expt.Software_ID . _NMR_spec_expt.Software_label . _NMR_spec_expt.Method_ID . _NMR_spec_expt.Method_label . _NMR_spec_expt.Pulse_seq_accession_BMRB_code . _NMR_spec_expt.Details . save_ save_3D-15N-13C-SPECIFIC_CP _NMR_spec_expt.Sf_category NMR_spectrometer_expt _NMR_spec_expt.Sf_framecode 3D-15N-13C-SPECIFIC_CP _NMR_spec_expt.Entry_ID 10022 _NMR_spec_expt.ID 6 _NMR_spec_expt.Name 3D-15N-13C-SPECIFIC_CP _NMR_spec_expt.Type . _NMR_spec_expt.Sample_volume . _NMR_spec_expt.Sample_volume_units . _NMR_spec_expt.NMR_tube_type . _NMR_spec_expt.Sample_spinning_rate . _NMR_spec_expt.Sample_angle . _NMR_spec_expt.NMR_spectrometer_ID 1 _NMR_spec_expt.NMR_spectrometer_label $spectrometer_1 _NMR_spec_expt.NMR_spectrometer_probe_ID . _NMR_spec_expt.NMR_spectrometer_probe_label . _NMR_spec_expt.Carrier_freq_switch_time . _NMR_spec_expt.Software_ID . _NMR_spec_expt.Software_label . _NMR_spec_expt.Method_ID . _NMR_spec_expt.Method_label . _NMR_spec_expt.Pulse_seq_accession_BMRB_code . _NMR_spec_expt.Details . save_ save_2D-13C-HH-SPIN_DIFF _NMR_spec_expt.Sf_category NMR_spectrometer_expt _NMR_spec_expt.Sf_framecode 2D-13C-HH-SPIN_DIFF _NMR_spec_expt.Entry_ID 10022 _NMR_spec_expt.ID 7 _NMR_spec_expt.Name 2D-13C-HH-SPIN_DIFF _NMR_spec_expt.Type . _NMR_spec_expt.Sample_volume . _NMR_spec_expt.Sample_volume_units . _NMR_spec_expt.NMR_tube_type . _NMR_spec_expt.Sample_spinning_rate . _NMR_spec_expt.Sample_angle . _NMR_spec_expt.NMR_spectrometer_ID 2 _NMR_spec_expt.NMR_spectrometer_label $spectrometer_2 _NMR_spec_expt.NMR_spectrometer_probe_ID . _NMR_spec_expt.NMR_spectrometer_probe_label . _NMR_spec_expt.Carrier_freq_switch_time . _NMR_spec_expt.Software_ID . _NMR_spec_expt.Software_label . _NMR_spec_expt.Method_ID . _NMR_spec_expt.Method_label . _NMR_spec_expt.Pulse_seq_accession_BMRB_code . _NMR_spec_expt.Details . save_ #################### # NMR parameters # #################### ############################## # Assigned chemical shifts # ############################## ################################ # Chemical shift referencing # ################################ save_reference_1 _Chem_shift_reference.Sf_category chem_shift_reference _Chem_shift_reference.Sf_framecode reference_1 _Chem_shift_reference.Entry_ID 10022 _Chem_shift_reference.ID 1 _Chem_shift_reference.Details . loop_ _Chem_shift_ref.Atom_type _Chem_shift_ref.Atom_isotope_number _Chem_shift_ref.Mol_common_name _Chem_shift_ref.Atom_group _Chem_shift_ref.Concentration_val _Chem_shift_ref.Concentration_units _Chem_shift_ref.Solvent _Chem_shift_ref.Rank _Chem_shift_ref.Chem_shift_units _Chem_shift_ref.Chem_shift_val _Chem_shift_ref.Ref_method _Chem_shift_ref.Ref_type _Chem_shift_ref.Indirect_shift_ratio _Chem_shift_ref.External_ref_loc _Chem_shift_ref.External_ref_sample_geometry _Chem_shift_ref.External_ref_axis _Chem_shift_ref.Indirect_shift_ratio_cit_ID _Chem_shift_ref.Indirect_shift_ratio_cit_label _Chem_shift_ref.Ref_correction_type _Chem_shift_ref.Correction_val _Chem_shift_ref.Correction_val_cit_ID _Chem_shift_ref.Correction_val_cit_label _Chem_shift_ref.Entry_ID _Chem_shift_ref.Chem_shift_reference_ID C 13 DSS 'methyl protons' . . . . ppm 0.0 . indirect 0.251449530 . . . . . . . . . 10022 1 N 15 DSS 'methyl protons' . . . . ppm 0.0 . indirect 0.101329118 . . . . . . . . . 10022 1 stop_ save_ ################################### # Assigned chemical shift lists # ################################### ################################################################### # Chemical Shift Ambiguity Index Value Definitions # # # # The values other than 1 are used for those atoms with different # # chemical shifts that cannot be assigned to stereospecific atoms # # or to specific residues or chains. # # # # Index Value Definition # # # # 1 Unique (including isolated methyl protons, # # geminal atoms, and geminal methyl # # groups with identical chemical shifts) # # (e.g. ILE HD11, HD12, HD13 protons) # # 2 Ambiguity of geminal atoms or geminal methyl # # proton groups (e.g. ASP HB2 and HB3 # # protons, LEU CD1 and CD2 carbons, or # # LEU HD11, HD12, HD13 and HD21, HD22, # # HD23 methyl protons) # # 3 Aromatic atoms on opposite sides of # # symmetrical rings (e.g. TYR HE1 and HE2 # # protons) # # 4 Intraresidue ambiguities (e.g. LYS HG and # # HD protons or TRP HZ2 and HZ3 protons) # # 5 Interresidue ambiguities (LYS 12 vs. LYS 27) # # 6 Intermolecular ambiguities (e.g. ASP 31 CA # # in monomer 1 and ASP 31 CA in monomer 2 # # of an asymmetrical homodimer, duplex # # DNA assignments, or other assignments # # that may apply to atoms in one or more # # molecule in the molecular assembly) # # 9 Ambiguous, specific ambiguity not defined # # # ################################################################### save_chemical_shift_1 _Assigned_chem_shift_list.Sf_category assigned_chemical_shifts _Assigned_chem_shift_list.Sf_framecode chemical_shift_1 _Assigned_chem_shift_list.Entry_ID 10022 _Assigned_chem_shift_list.ID 1 _Assigned_chem_shift_list.Sample_condition_list_ID 1 _Assigned_chem_shift_list.Sample_condition_list_label $condition_1 _Assigned_chem_shift_list.Chem_shift_reference_ID 1 _Assigned_chem_shift_list.Chem_shift_reference_label $reference_1 _Assigned_chem_shift_list.Chem_shift_1H_err . _Assigned_chem_shift_list.Chem_shift_13C_err . _Assigned_chem_shift_list.Chem_shift_15N_err . _Assigned_chem_shift_list.Chem_shift_31P_err . _Assigned_chem_shift_list.Chem_shift_2H_err . _Assigned_chem_shift_list.Chem_shift_19F_err . _Assigned_chem_shift_list.Error_derivation_method . _Assigned_chem_shift_list.Details . _Assigned_chem_shift_list.Text_data_format . _Assigned_chem_shift_list.Text_data . loop_ _Chem_shift_experiment.Experiment_ID _Chem_shift_experiment.Experiment_name _Chem_shift_experiment.Sample_ID _Chem_shift_experiment.Sample_label _Chem_shift_experiment.Sample_state _Chem_shift_experiment.Entry_ID _Chem_shift_experiment.Assigned_chem_shift_list_ID 1 2D-3D-13C-13C-RFDR 1 $sample_1 isotripic 10022 1 2 2D-3D-13C-13C-DARR 1 $sample_1 isotripic 10022 1 3 2D-13C-13C-SPCz5 1 $sample_1 isotripic 10022 1 4 2D-13C-13C-INADEQUATE 1 $sample_1 isotripic 10022 1 5 2D-3D-15N-13C-RFDR 1 $sample_1 isotripic 10022 1 6 3D-15N-13C-SPECIFIC_CP 1 $sample_1 isotripic 10022 1 stop_ loop_ _Atom_chem_shift.ID _Atom_chem_shift.Assembly_atom_ID _Atom_chem_shift.Entity_assembly_ID _Atom_chem_shift.Entity_ID _Atom_chem_shift.Comp_index_ID _Atom_chem_shift.Seq_ID _Atom_chem_shift.Comp_ID _Atom_chem_shift.Atom_ID _Atom_chem_shift.Atom_type _Atom_chem_shift.Atom_isotope_number _Atom_chem_shift.Val _Atom_chem_shift.Val_err _Atom_chem_shift.Assign_fig_of_merit _Atom_chem_shift.Ambiguity_code _Atom_chem_shift.Occupancy _Atom_chem_shift.Resonance_ID _Atom_chem_shift.Auth_entity_assembly_ID _Atom_chem_shift.Auth_asym_ID _Atom_chem_shift.Auth_seq_ID _Atom_chem_shift.Auth_comp_ID _Atom_chem_shift.Auth_atom_ID _Atom_chem_shift.Details _Atom_chem_shift.Entry_ID _Atom_chem_shift.Assigned_chem_shift_list_ID 1 . 1 1 1 1 SER C C 13 168.4 0.3 . 1 . . . . 20 SER C . 10022 1 2 . 1 1 1 1 SER CA C 13 58.2 0.3 . 1 . . . . 20 SER CA . 10022 1 3 . 1 1 1 1 SER CB C 13 65.6 0.3 . 1 . . . . 20 SER CB . 10022 1 4 . 1 1 1 1 SER N N 15 37.2 0.5 . 1 . . . . 20 SER N . 10022 1 5 . 1 1 2 2 ASN C C 13 172.3 0.3 . 1 . . . . 21 ASN C . 10022 1 6 . 1 1 2 2 ASN CA C 13 51.7 0.3 . 1 . . . . 21 ASN CA . 10022 1 7 . 1 1 2 2 ASN CB C 13 41.3 0.3 . 1 . . . . 21 ASN CB . 10022 1 8 . 1 1 2 2 ASN CG C 13 177.3 0.3 . 1 . . . . 21 ASN CG . 10022 1 9 . 1 1 2 2 ASN N N 15 118 0.5 . 1 . . . . 21 ASN N . 10022 1 10 . 1 1 2 2 ASN ND2 N 15 119.49 0.5 . 1 . . . . 21 ASN ND2 . 10022 1 11 . 1 1 3 3 PHE C C 13 172.3 0.3 . 1 . . . . 22 PHE C . 10022 1 12 . 1 1 3 3 PHE CA C 13 55.7 0.3 . 1 . . . . 22 PHE CA . 10022 1 13 . 1 1 3 3 PHE CB C 13 40.5 0.3 . 1 . . . . 22 PHE CB . 10022 1 14 . 1 1 3 3 PHE CG C 13 137.9 0.3 . 1 . . . . 22 PHE CG . 10022 1 15 . 1 1 3 3 PHE CD1 C 13 132.6 0.3 . 1 . . . . 22 PHE CD1 . 10022 1 16 . 1 1 3 3 PHE CD2 C 13 132.6 0.3 . 1 . . . . 22 PHE CD2 . 10022 1 17 . 1 1 3 3 PHE CE1 C 13 131.47 0.3 . 1 . . . . 22 PHE CE1 . 10022 1 18 . 1 1 3 3 PHE CE2 C 13 131.47 0.3 . 1 . . . . 22 PHE CE2 . 10022 1 19 . 1 1 3 3 PHE CZ C 13 130.37 0.3 . 1 . . . . 22 PHE CZ . 10022 1 20 . 1 1 3 3 PHE N N 15 120.6 0.5 . 1 . . . . 22 PHE N . 10022 1 21 . 1 1 4 4 LEU C C 13 173.2 0.3 . 1 . . . . 23 LEU C . 10022 1 22 . 1 1 4 4 LEU CA C 13 54.2 0.3 . 1 . . . . 23 LEU CA . 10022 1 23 . 1 1 4 4 LEU CB C 13 44.4 0.3 . 1 . . . . 23 LEU CB . 10022 1 24 . 1 1 4 4 LEU CG C 13 29.1 0.3 . 1 . . . . 23 LEU CG . 10022 1 25 . 1 1 4 4 LEU CD1 C 13 24.07 0.3 . 2 . . . . 23 LEU CD1 . 10022 1 26 . 1 1 4 4 LEU CD2 C 13 23.74 0.3 . 2 . . . . 23 LEU CD2 . 10022 1 27 . 1 1 4 4 LEU N N 15 121.4 0.5 . 1 . . . . 23 LEU N . 10022 1 28 . 1 1 5 5 ASN C C 13 172.1 0.3 . 1 . . . . 24 ASN C . 10022 1 29 . 1 1 5 5 ASN CA C 13 51.8 0.3 . 1 . . . . 24 ASN CA . 10022 1 30 . 1 1 5 5 ASN CB C 13 41.9 0.3 . 1 . . . . 24 ASN CB . 10022 1 31 . 1 1 5 5 ASN CG C 13 175.3 0.3 . 1 . . . . 24 ASN CG . 10022 1 32 . 1 1 5 5 ASN N N 15 123.8 0.5 . 1 . . . . 24 ASN N . 10022 1 33 . 1 1 5 5 ASN ND2 N 15 118.72 0.5 . 1 . . . . 24 ASN ND2 . 10022 1 34 . 1 1 6 6 CYS C C 13 170.3 0.3 . 1 . . . . 25 CYS C . 10022 1 35 . 1 1 6 6 CYS CA C 13 56.3 0.3 . 1 . . . . 25 CYS CA . 10022 1 36 . 1 1 6 6 CYS CB C 13 29.7 0.3 . 1 . . . . 25 CYS CB . 10022 1 37 . 1 1 6 6 CYS N N 15 124.6 0.5 . 1 . . . . 25 CYS N . 10022 1 38 . 1 1 7 7 TYR C C 13 172.7 0.3 . 1 . . . . 26 TYR C . 10022 1 39 . 1 1 7 7 TYR CA C 13 55.7 0.3 . 1 . . . . 26 TYR CA . 10022 1 40 . 1 1 7 7 TYR CB C 13 40.7 0.3 . 1 . . . . 26 TYR CB . 10022 1 41 . 1 1 7 7 TYR CG C 13 128.2 0.3 . 1 . . . . 26 TYR CG . 10022 1 42 . 1 1 7 7 TYR CD1 C 13 133.2 0.3 . 1 . . . . 26 TYR CD1 . 10022 1 43 . 1 1 7 7 TYR CD2 C 13 133.2 0.3 . 1 . . . . 26 TYR CD2 . 10022 1 44 . 1 1 7 7 TYR CE1 C 13 118.16 0.3 . 1 . . . . 26 TYR CE1 . 10022 1 45 . 1 1 7 7 TYR CE2 C 13 118.16 0.3 . 1 . . . . 26 TYR CE2 . 10022 1 46 . 1 1 7 7 TYR CZ C 13 155.35 0.3 . 1 . . . . 26 TYR CZ . 10022 1 47 . 1 1 7 7 TYR N N 15 131.1 0.5 . 1 . . . . 26 TYR N . 10022 1 48 . 1 1 8 8 VAL C C 13 173.7 0.3 . 1 . . . . 27 VAL C . 10022 1 49 . 1 1 8 8 VAL CA C 13 59.6 0.3 . 1 . . . . 27 VAL CA . 10022 1 50 . 1 1 8 8 VAL CB C 13 34.4 0.3 . 1 . . . . 27 VAL CB . 10022 1 51 . 1 1 8 8 VAL CG1 C 13 20.5 0.3 . 1 . . . . 27 VAL CG1 . 10022 1 52 . 1 1 8 8 VAL CG2 C 13 20.5 0.3 . 1 . . . . 27 VAL CG2 . 10022 1 53 . 1 1 8 8 VAL N N 15 126.1 0.5 . 1 . . . . 27 VAL N . 10022 1 54 . 1 1 9 9 SER C C 13 175.9 0.3 . 1 . . . . 28 SER C . 10022 1 55 . 1 1 9 9 SER CA C 13 56.3 0.3 . 1 . . . . 28 SER CA . 10022 1 56 . 1 1 9 9 SER CB C 13 65.1 0.3 . 1 . . . . 28 SER CB . 10022 1 57 . 1 1 9 9 SER N N 15 117.2 0.5 . 1 . . . . 28 SER N . 10022 1 58 . 1 1 10 10 GLY C C 13 172.2 0.3 . 1 . . . . 29 GLY C . 10022 1 59 . 1 1 10 10 GLY CA C 13 45.8 0.3 . 1 . . . . 29 GLY CA . 10022 1 60 . 1 1 10 10 GLY N N 15 107.7 0.5 . 1 . . . . 29 GLY N . 10022 1 61 . 1 1 11 11 PHE C C 13 173.5 0.3 . 1 . . . . 30 PHE C . 10022 1 62 . 1 1 11 11 PHE CA C 13 55.7 0.3 . 1 . . . . 30 PHE CA . 10022 1 63 . 1 1 11 11 PHE CB C 13 38.8 0.3 . 1 . . . . 30 PHE CB . 10022 1 64 . 1 1 11 11 PHE CG C 13 139.3 0.3 . 1 . . . . 30 PHE CG . 10022 1 65 . 1 1 11 11 PHE CD1 C 13 132.3 0.3 . 1 . . . . 30 PHE CD1 . 10022 1 66 . 1 1 11 11 PHE CD2 C 13 132.3 0.3 . 1 . . . . 30 PHE CD2 . 10022 1 67 . 1 1 11 11 PHE CE1 C 13 131.48 0.3 . 1 . . . . 30 PHE CE1 . 10022 1 68 . 1 1 11 11 PHE CE2 C 13 131.48 0.3 . 1 . . . . 30 PHE CE2 . 10022 1 69 . 1 1 11 11 PHE CZ C 13 130.09 0.3 . 1 . . . . 30 PHE CZ . 10022 1 70 . 1 1 11 11 PHE N N 15 120.3 0.5 . 1 . . . . 30 PHE N . 10022 1 71 . 1 1 12 12 HIS C C 13 175.7 0.3 . 1 . . . . 31 HIS C . 10022 1 72 . 1 1 12 12 HIS CA C 13 56.3 0.3 . 1 . . . . 31 HIS CA . 10022 1 73 . 1 1 12 12 HIS CB C 13 29.2 0.3 . 1 . . . . 31 HIS CB . 10022 1 74 . 1 1 12 12 HIS CG C 13 130.6 0.3 . 1 . . . . 31 HIS CG . 10022 1 75 . 1 1 12 12 HIS CD2 C 13 122.05 0.3 . 1 . . . . 31 HIS CD2 . 10022 1 76 . 1 1 12 12 HIS CE1 C 13 135.3 0.3 . 1 . . . . 31 HIS CE1 . 10022 1 77 . 1 1 12 12 HIS N N 15 122.6 0.5 . 1 . . . . 31 HIS N . 10022 1 78 . 1 1 12 12 HIS ND1 N 15 176.6 0.5 . 4 . . . . 31 HIS ND1 . 10022 1 79 . 1 1 12 12 HIS NE2 N 15 180.4 0.5 . 4 . . . . 31 HIS NE2 . 10022 1 80 . 1 1 13 13 PRO C C 13 176.4 0.3 . 1 . . . . 32 PRO C . 10022 1 81 . 1 1 13 13 PRO CA C 13 62.4 0.3 . 1 . . . . 32 PRO CA . 10022 1 82 . 1 1 13 13 PRO CB C 13 32.4 0.3 . 1 . . . . 32 PRO CB . 10022 1 83 . 1 1 13 13 PRO CG C 13 27.1 0.3 . 1 . . . . 32 PRO CG . 10022 1 84 . 1 1 13 13 PRO CD C 13 50.1 0.3 . 1 . . . . 32 PRO CD . 10022 1 85 . 1 1 13 13 PRO N N 15 134.9 0.5 . 1 . . . . 32 PRO N . 10022 1 86 . 1 1 14 14 SER C C 13 172 0.3 . 1 . . . . 33 SER C . 10022 1 87 . 1 1 14 14 SER CA C 13 56.8 0.3 . 1 . . . . 33 SER CA . 10022 1 88 . 1 1 14 14 SER CB C 13 62.6 0.3 . 1 . . . . 33 SER CB . 10022 1 89 . 1 1 14 14 SER N N 15 118.7 0.5 . 1 . . . . 33 SER N . 10022 1 90 . 1 1 15 15 ASP C C 13 172.5 0.3 . 1 . . . . 34 ASP C . 10022 1 91 . 1 1 15 15 ASP CA C 13 51.2 0.3 . 1 . . . . 34 ASP CA . 10022 1 92 . 1 1 15 15 ASP CB C 13 42.1 0.3 . 1 . . . . 34 ASP CB . 10022 1 93 . 1 1 15 15 ASP CG C 13 175.1 0.3 . 1 . . . . 34 ASP CG . 10022 1 94 . 1 1 15 15 ASP N N 15 129.6 0.5 . 1 . . . . 34 ASP N . 10022 1 95 . 1 1 16 16 ILE C C 13 172.5 0.3 . 1 . . . . 35 ILE C . 10022 1 96 . 1 1 16 16 ILE CA C 13 59.6 0.3 . 1 . . . . 35 ILE CA . 10022 1 97 . 1 1 16 16 ILE CB C 13 41.9 0.3 . 1 . . . . 35 ILE CB . 10022 1 98 . 1 1 16 16 ILE CG1 C 13 27.1 0.3 . 4 . . . . 35 ILE CG1 . 10022 1 99 . 1 1 16 16 ILE CG2 C 13 17.4 0.3 . 4 . . . . 35 ILE CG2 . 10022 1 100 . 1 1 16 16 ILE CD1 C 13 13.5 0.3 . 1 . . . . 35 ILE CD1 . 10022 1 101 . 1 1 16 16 ILE N N 15 123.1 0.5 . 1 . . . . 35 ILE N . 10022 1 102 . 1 1 17 17 GLU C C 13 173.2 0.3 . 1 . . . . 36 GLU C . 10022 1 103 . 1 1 17 17 GLU CA C 13 53.8 0.3 . 1 . . . . 36 GLU CA . 10022 1 104 . 1 1 17 17 GLU CB C 13 31.1 0.3 . 1 . . . . 36 GLU CB . 10022 1 105 . 1 1 17 17 GLU CG C 13 32.4 0.3 . 1 . . . . 36 GLU CG . 10022 1 106 . 1 1 17 17 GLU CD C 13 180.05 0.3 . 1 . . . . 36 GLU CD . 10022 1 107 . 1 1 17 17 GLU N N 15 126.4 0.5 . 1 . . . . 36 GLU N . 10022 1 108 . 1 1 18 18 VAL C C 13 173.2 0.3 . 1 . . . . 37 VAL C . 10022 1 109 . 1 1 18 18 VAL CA C 13 60.1 0.3 . 1 . . . . 37 VAL CA . 10022 1 110 . 1 1 18 18 VAL CB C 13 33.9 0.3 . 1 . . . . 37 VAL CB . 10022 1 111 . 1 1 18 18 VAL CG1 C 13 19.9 0.3 . 1 . . . . 37 VAL CG1 . 10022 1 112 . 1 1 18 18 VAL CG2 C 13 19.9 0.3 . 1 . . . . 37 VAL CG2 . 10022 1 113 . 1 1 18 18 VAL N N 15 126.4 0.5 . 1 . . . . 37 VAL N . 10022 1 114 . 1 1 19 19 ASP C C 13 173 0.3 . 1 . . . . 38 ASP C . 10022 1 115 . 1 1 19 19 ASP CA C 13 51 0.3 . 1 . . . . 38 ASP CA . 10022 1 116 . 1 1 19 19 ASP CB C 13 39.9 0.3 . 1 . . . . 38 ASP CB . 10022 1 117 . 1 1 19 19 ASP CG C 13 175.61 0.3 . 1 . . . . 38 ASP CG . 10022 1 118 . 1 1 19 19 ASP N N 15 124.7 0.5 . 1 . . . . 38 ASP N . 10022 1 119 . 1 1 20 20 LEU C C 13 170.4 0.3 . 1 . . . . 39 LEU C . 10022 1 120 . 1 1 20 20 LEU CA C 13 53 0.3 . 1 . . . . 39 LEU CA . 10022 1 121 . 1 1 20 20 LEU CB C 13 44.6 0.3 . 1 . . . . 39 LEU CB . 10022 1 122 . 1 1 20 20 LEU CG C 13 26.9 0.3 . 1 . . . . 39 LEU CG . 10022 1 123 . 1 1 20 20 LEU CD1 C 13 24.3 0.3 . 2 . . . . 39 LEU CD1 . 10022 1 124 . 1 1 20 20 LEU CD2 C 13 23.7 0.3 . 2 . . . . 39 LEU CD2 . 10022 1 125 . 1 1 20 20 LEU N N 15 124.4 0.5 . 1 . . . . 39 LEU N . 10022 1 126 . 1 1 21 21 LEU C C 13 173.8 0.3 . 1 . . . . 40 LEU C . 10022 1 127 . 1 1 21 21 LEU CA C 13 53.5 0.3 . 1 . . . . 40 LEU CA . 10022 1 128 . 1 1 21 21 LEU CB C 13 43.1 0.3 . 1 . . . . 40 LEU CB . 10022 1 129 . 1 1 21 21 LEU CG C 13 28.6 0.3 . 1 . . . . 40 LEU CG . 10022 1 130 . 1 1 21 21 LEU CD1 C 13 24.6 0.3 . 2 . . . . 40 LEU CD1 . 10022 1 131 . 1 1 21 21 LEU CD2 C 13 23.8 0.3 . 2 . . . . 40 LEU CD2 . 10022 1 132 . 1 1 21 21 LEU N N 15 123.8 0.5 . 1 . . . . 40 LEU N . 10022 1 133 . 1 1 22 22 LYS C C 13 174.7 0.3 . 1 . . . . 41 LYS C . 10022 1 134 . 1 1 22 22 LYS CA C 13 54.3 0.3 . 1 . . . . 41 LYS CA . 10022 1 135 . 1 1 22 22 LYS CB C 13 31.3 0.3 . 1 . . . . 41 LYS CB . 10022 1 136 . 1 1 22 22 LYS CG C 13 26.9 0.3 . 1 . . . . 41 LYS CG . 10022 1 137 . 1 1 22 22 LYS CD C 13 29.4 0.3 . 1 . . . . 41 LYS CD . 10022 1 138 . 1 1 22 22 LYS CE C 13 42.35 0.3 . 1 . . . . 41 LYS CE . 10022 1 139 . 1 1 22 22 LYS N N 15 118.4 0.5 . 1 . . . . 41 LYS N . 10022 1 stop_ loop_ _Ambiguous_atom_chem_shift.Ambiguous_shift_set_ID _Ambiguous_atom_chem_shift.Atom_chem_shift_ID _Ambiguous_atom_chem_shift.Entry_ID _Ambiguous_atom_chem_shift.Assigned_chem_shift_list_ID 1 78 10022 1 1 79 10022 1 2 98 10022 1 2 99 10022 1 stop_ save_